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ABSTRACT 
In Drosophila the three yolk protein (yp) genes are expressed in the adult female fat 
body and ovary. The yolk proteins (YP5) are stored in the oocyte for utilisation 
during embryogenesis. Within the intergenic region of ypi and yp2, a fat body 
enhancer (FBE) and two ovarian enhancers have been found to direct YP1 and YP2 
tissue- and sex-specific expression. The male and female forms of Doublesex protein 
(DSXM and DSXF respectively) have been found to bind to the FBE and are thought 
to confer the sex-specificity of yp expression to the fat body of females only. Other 
possible trans-acting factors have also been shown to bind to the FBE in vivo, these 
include AEF-1 and C/EBP proteins. The dsx gene is at the end of the sex 
determination pathway, other genes that operate from this branch of the pathway 
include hermaphrodite (her) and into-sex (ix), and it is possible that HER and IX 
proteins could also regulateyp gene expression. 
Upstream of yp3 are sequences that direct female-, fat body-specific yp3 expression 
(FBE3) and ovarian-specific yp3 expression (0E3). This project involved analysis of 
FBE3 and 0E3 to gain thrther understanding of the regulation of yp3 expression. The 
role of DSX in the regulation of yp3 has been investigated; the FBE3 was divided into 
smaller subfragments and it was determined that one of these fragments can bind 
DSX in vitro. These subfragments were cloned into reporter gene constructs to test 
their capabilities in directing correct lacZ expression pattern in vivo, using P-element 
mediated transformation. This revealed that the fragment capable of binding DSX in 
vitro, could direct lacZ expression in fat body cells, but this expression was not sex-
specific, both male and female fat bodies showed reporter gene expression. C/EBP 
was reported to bind to the FBE in vitro and considered to be a potential activator of 
yp gene expression. From C/EBP mutant analysis, there was no observed difference 
from wild type in the level of YP expression in vivo; thus it is unlikely that C/EBP 
has a regulatory role in yp gene expression in the fat body. 
4 
In situ hybridisations were performed using yp probes on Drosophila ovaries, this 
revealed that the yps are expressed in the ovarian follicle cells during stages 8-10b of 
oogenesis. 0E3 was found to contain a sequence conserved between several Dipteran 
insects, a lSObp PCR fragment containing this sequence is able to confer ovarian 
expression. Candidate trans-acting factors for the regulation of ovary-specific yp 
expression were investigated to determine if they are present at the correct 
developmental stages by in situ hybridisation. 
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CHAPTER 1 
INTRODUCTION 
The yolk protein genes of Drosophila melanogaster 
Sexual differentiation in Drosophila melanogaster is the result of differential 
activation and expression of a hierarchy of sex determination genes. The 
understanding of the mechanisms involved is of geat importance in developmental 
biology. The sex determination pathway has been well characterised at both genetic 
and molecular levels. However, only one direct link between the sex determination 
genes and the downstream sexual differentiation genes has been found; this is the 
regulation of the yolk protein (yp) genes. 
The yolk proteins are synthesised in the fat body and ovarian follicle cells of the 
adult female and are subsequently transported to the oocyte during oogenesis, where 
they are stored for utilisation during embryogenesis. The expression of the yolk 
proteins is not only controlled by the sex determination hierarchy, but also the 
nutritional status of the fly and the insect hormones: ecdysone and juvenile honnone. 
The interactions between all these factors are responsible for the co-ordinated 
expression of the yolkprotein genes in the right sex, in specific tissues and under the 
appropriate environmental conditions. 
There are three yolk protein genes in Drosophila (ypi, yp2 and yp3), and most 
investigations into the regulation of the yolk protein genes have concentrated upon 
yp] and yp2. Consequently, in comparison to yp] and yp2, very little is known about 
the regulation of yp3. 
The aim of this PhD project was to further characterise yp3 cis-acting DNA 
sequences and to identify trans-acting factors involved in directing yp3 gene 
expression in the ovary and the fat body. 
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1.1 OOGENESIS 
The adult female Drosophila melanogaster contains two ovaries, each consisting of 
15-20 ovarioles organised in parallel (Figure 1.1 A). Each ovariole contains a row of 
developmentally ordered egg chambers which can be divided into two sections: the 
germarium and the vitellarium. In the germarium cell proliferation and differentiation 
produces the three main cell types in the ovary; the oocyte, the nurse cells and the 
follicle cells. At the anterior tip of the germarium (Figure 1.IC), a small number of 
germ line stem cells (Weischaus and Szabad, 1979) divide to produce two daughter 
cells; another stem cell and a cystoblast. The cystoblast undergoes 4 mitotic divisions 
with incomplete cytokinesis, which gives rise to a cluster of 16 cells connected by 
intercellular bridges called ring canals. Only two of the cells have maximum four ring 
canals and it is always one of these cells which becomes the oocyte (Koch et al., 
1967), the other 15 cells will become the nurse cells. Before the cluster of cells exit 
the germarium and enter the vitellarium they are surrounded by small follicle cells to 
form the egg chamber. Unlike the oocyte and nurse cells, the follicle cells are somatic 
cells derived from the mesoderm. The egg chamber undergoes significant changes in 
morphology upon entering the vitellarium; these have been classified into 14 distinct 
stages by King (1970). 
The vitellarium contains a series of progressively older egg chambers in varying 
developmental stages, connected by follicular stalk cells, some of these stages are 
shown in Figure 1.1 B. Stages 1-7 are termed the previtellogenic stages, and during 
this period the oocyte and the nurse cells are roughly equal in size, and the oocyte is 
always the most posterior germ line cell in the egg chamber. 
During stages 8-10 vitellogenesis proceeds; the oocyte undergoes rapid gowth as 
yolk proteins, synthesised in the fat body and the follicle cells, are taken up into the 
oocyte by receptor-mediated endocytosis and accumulated as yolk ganules. At the 
same time in the vitellarium, the 15 nurse cells enlarge and become polyploid (Jacob 
14 
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Figure 1.1 
Drosophila inelanogaster ovaries and the developmental sequence of oogenesis. 
Dorsal view of the internal reproductive system of an adult female Drosophila 
(adapted from Mahowald and Kambysellis, 1980). Two ovarioles have been pulled 
loose from the right ovary. 
Diagram of an adult wild type ovariole (adapted from Peifer et al., 1993). 
Diagram of a germarium (adapted from Mahowald and Kambysellis, 1980). 
ant, anterior; be, border cells; fe, follicle cells; ne, nurse cells; oc, oocyte; pc, polar 
cells; post, posterior; ppc, posterior polar cells; se, stalk cells; ST, stage. 
Region 2. R.gion 2b 
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and Stirling, 1959), which enables them to synthesise large quantities of proteins and 
RNAs which are transferred into the oocyte at a later stage. Most of the RNA 
synthesised is ribosomal (Mahowald and Tiefert, 1970), some is mRNA which is 
involved in determining egg polarity and subsequent aspects of embryonic 
development (reviewed by Lasko, 1994). The internal layers of the vitelline 
membrane are also synthesised by the follicle cells during this time. The follicle cells 
also undergo a series of migrations during stages 8-10. The border cells, a goup of 6-
10 follicle cells located at the anterior of the egg chamber, migrate in a posterior 
direction between the nurse cells until they reach the nurse cell-oocyte interface. 
During stage 10 they migrate dorsally along the interface until they are located 
opposite the oocyte nucleus, at a later stage the border cells are involved in creating 
the micropylar pore. The follicle cell monolayer covers the entire egg chamber until 
stage 9 when the anterior follicle cells overlaying the nurse cells migrate posteriorly 
to surround the oocyte. By stage 1 OA the nurse cells have very few follicle cells 
associated with them and the oocyte is covered by a layer of thick columnar follicle 
cells. 
During stages 1OB-13 the majority of the nurse cell cytoplasm is quickly transferred 
into the oocyte via the ring canals. Following the completion of their migration at 
stage 11, the follicle cells synthesise large amounts of chorion proteins to form the 
eggshell. As the chorion is deposited, other structures are also assembled; the 
micropylar apparatus through which sperm entry takes place, and the dorsal 
appendages used for embryonic respiration are formed. When the eggshell is 
completed, the nurse cells and the follicle cells degenerate and die, leaving behind the 
mature egg. 
The follicle cells are particularly relevant to this project because they are the site of 
yolk protein synthesis in the Drosophila ovary. The follicle cells differentiate from 
the somatic profollicle cells that surround the nurse cells and oocyte in the germarium 
(reviewed by Margaritis et aL, 1980). During stages 2-5 the follicle cells proliferate to 
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produce approximately 1000 follicular epithelial cells which differentiate to form all 
the follicle cell subtypes, shown in Figure 1.2. The division of these precursor cells 
ceases by stage 6, when they differentiate into three follicle cell subtypes: border 
cells, cells overlying the nurse cells, and columnar cells. By stage 11, these cells 
undergo differentiation into three additional cell types: anterior pole cells, posterior 
pole cells and columnar main body cells. 
1.2 THE YOLK PROTEINS 
There are three yolk proteins (YPs) synthesised in Drosophila, and their 
approximate sizes are: 47 kDa (YP1), 46 kDa (YP2) and 45 kDa (YP3). The proteins 
are produced in the female fat body (a tissue considered to be analogous to the 
vertebrate liver) and the follicle cells surrounding oocytes undergoing vitellogenesis 
(Bownes and Hames, 1978; Brennan et at, 1982). Yolk proteins synthesised in the 
fat body are secreted into the haemolymph (Bownes, 1986), and those made in the 
follicle cells are secreted unidirectionally towards the oocyte membrane (Butterworth 
ci al., 1992). The YPs are taken up into the oocyte by receptor-mediated endocytosis 
and assembled into yolk storage granules until they are required (Giorgi ci al., 1979). 
The site of yolk protein synthesis does not appear to confer any differences in their 
biochemical properties. However, there does appear to be differences in the rates of 
YP synthesis between the two tissues. In the fat body cells they are all present in 
equal amounts, but in the ovary YP3 synthesis is reduced by approximately 25% 
compared to YP1 and YP2 (Brennan ci al., 1982; Isaac and Bownes, 1982). The 
transcription rates were found to be the same for all three yolk protein genes (yp 
genes) but the levels of mRNA were different, with yp3 being less (Isaac and 
Bownes, 1982). The yp3 transcripts were found to be less stable in the ovary and 
thus much less YP3 is produced by this tissue (Williams and Bownes, 1986). 
The function of the yolk proteins is to provide a nutritional supply of amino acids 
for utilisation during embryonic development. The YPs have also been shown to 
16 
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Figure 1.2 
The differentiation lineage of Drosophila ovarian follicle cells (Logan and Wensink, 
1980). 
Each differentiation lineage is indicated by arrows. The approximate developmental 
stage of appearance (s) and the approximate number of cells (n) are listed under each 
cell type name. 
Follicular Epithelial Cells (fe) 
s6, nl000 
Columnar Cells (cc) Border Cells (be) 
s7, n6lfl s8-9, n900 
it. 
Cells Covering 
Niirp Cells (cn) 
i50-100 
Anterior Pole Cells (ap) 
slO-li, n300 
Columnar Main 
Body Cells (emb) 
slO, n500 
1. 
Main Body Cells (mb) 
sll,n500 
Posterior Pole Cells (pp) 
s?, n30 
carry ecdysteroid hormones, in an inactive form, into the oocyte for release during 
embryogenesis (Bownes et al., 1988). 
1.3 THE YOLK PROTEIN GENES 
The yolk protein genes are a small family encoded by single copy genes on the X 
chromosome (Barnett et al., 1980). The genomic arrangement of the three yp genes is 
shown in Figure 1.3. yp] and yp2 are located at position 8F-9A and are divergently 
transcribed with each containing one intron, they are separated by a shared intergenic 
region of 1226bp. yp3 is located at position 12BC, isolated from yp] and yp2, and 
contains two introns (Garabedian et al., 1987). The first intron of yp3 is located at a 
similar position to those of ypi and yp2, relative to the transcriptional start site of 
each gene. Single transcripts are detected for ypi and yp3 which are estimated to be 
approximately 1.60 kb and 1.54 kb respectively. Two transcripts are detected for 
yp2 of approximately 1.67 kb and 1.60 kb, these are found to differ at their 3' ends 
(Hung et al., 1982). There is a high level of sequence similarity between the 
nucleotide sequences of these three genes, which is highest at the 3' translated 
regions. Between ypl and yp2, and ypl and yp3 there is 53% identity, and there is 
48% identity between yp2 and yp3. Due to the similarities in gene structure and 
sequence identities, it is considered that these genes may have arisen from duplication 
events during evolution (Yan et al., 1987). 
1.4 CIS-ACTING SEQUENCES FOR THE YOLK PROTEIN GENES 
Cis-acting sequences governing yp gene expression have been identified using 
fragments of DNA flanking the yp genes fused to reporter genes. After P-element 
mediated germ line transformation of these constructs, any regulatory effects due to 
the yp flanking sequences can be determined by analysis of the transgenic flies 
produced. 
17 
CHAPTER ONE: INTRODUCTION 
Figure 1.3 
Genomic arrangement of the three yolk protein genes. 
The location on the X chromosome is indicated. The clear boxes represent the jp 
coding sequences, and the hatched boxes represent introns. 
Transcripts are represented by arrows, with the arrowhead showing the direction of 
transcription, and spaces the location of the introns. The molecular weights of the 
mature polypeptides are given. 
Location on X chromosome 
12BC 	 8F-9A 
I 	yp3 	•ui,t' I 	YPI 	UI 	IU 	yp2 
Transcripts 




45kDa 	 47kDa 	 46kDa 
In the 1226bp intergenic region of ypi and yp2, several cis-acting sequences have been 
identified which are shared between the two genes, these are shown in Figure 1.4A. 
One of these sequences, the fat body enhancer (FBE), was localised to a 125bp 
fragment, sufficient for fat body, female-specific yp expression (Garabedian et al, 
1986). However, the FBE is not essential for the fat body, female-specific yp 
expression, and deletion of the FBE does not disrupt the expression pattern. Another 
region, located either within the upstream region conferring ovarian expression or 
within the yp2 coding sequence, has been identified to govern fat body, female-
specific expression (Abrahamsen et al., 1993). Thus there appear to be multiple sites, 
flanking ypi and yp2, which can confer fat body expression in females, but not in 
males. It is not known whether these sites normally provide independent regulation 
ofypi and yp2, or if these genes both use the same enhancers for female-specific fat 
body expression. There are also two ovarian enhancers, OE1 and OE2, that are 
necessary for the correct expression of ypi and yp2 in the ovary. OE1 is 30lbp and is 
located 43bp upstream of yp2, this fragment can be subdivided into two regions, both 
of which are needed to direct the timing of ypi and yp2 expression to the correct 
stages of oogenesis in the follicle cells. 0E2 is 1 QSbp and is located within the yp2 
coding region, 0E2 enhances levels of ovarian ypl transcripts but cannot regulate the 
expression to the correct stages of oogenesis (Logan et al., 1989; Logan and Wensink, 
1990). Therefore, to provide the correct levels and pattern expressions of ypl and 
yp2, both OE  and OE2 are required. 
For yp3, two cis-acting sequences, located 5' of the transcription start site, were 
found to be necessary for the ovarian and sex-specific fat body expression of the 
Drosophila yp3 gene. A 328bp ovarian region (0E3) is sufficient to limit reporter 
gene expression to the correct follicle cell types at the expected stages 8-10 of 
oogenesis. OE3 was only tested in the forward orientation with its native yp3 
promoter, and thus cannot formally be named an enhancer since it was not tested in 
the reverse orientation. A neighbouring 419bp sequence, termed FBE3, is able to 
direct reporter gene expression, from a heterologous promoter, in the fat body cells of 
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Figure 1.4 
The ypl and yp2 regions that contain transcription enhancer sequences. 
The genomic arrangement of yp] and yp2 is shown, with horizontal arrows 
representing the length and direction of transcripts, introns are indicated by spaces. 
Boxes show the location and sizes of the fat body enhancer (FBE), ovarian enhancer 
I (OE 1) and ovarian enhancer 2 (0E2). 
The yp3 gene, showing the identified ovary and fat body cis-regulatory regions. 
Nucleotide positions of restriction enzyme sites are given in relation to the yp3 
transcription start site. 
Not drawn to scale. 
ypi 	+1 	 yp2 
HindlIl 
V//A WI 
+1635 	 FBE 	 OR! 	 CR2 	 -2926 
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females, but not males (Ronaidson and Bownes, 1995). The position of these 
fragments relative to the yp3 transcription start site is shown in Figure 1.413. No 
other sequences in the upstream, downstream or coding regions were found to 
capable of regulating yp3 expression. It was noticed that some reporter constructs 
were subject to chromosomal position effects, and these effects were less frequent 
with fragments that directed transcription from the native yp promoter. This 
indicates that the hsp70 promoter (used as a heterologous promoter in some reporter 
constructs where a fragment is lacking the native promoter) may be more susceptible 
to the influences of nearby enhancers than the yp3 promoter, or differences may 
occur due to the organisation of sites in artificially created fusions (Ronaidson and 
Bownes, 1995). 
1.5 FACTORS REGULATING YOLK PROTEIN GENE EXPRESSION 
The regulation of the yolk protein genes is complex because the adult female fly must 
relate egg production to environmental conditions. The factors involved in controlling 
yp gene expression are: the nutritional status of the fly, the hormones ecdysone and 
juvenile hormone, the sex determination hierarchy and the tissue-specific factors 
required to give expression in the correct tissues at the correct developmental stages. 
1.5.1 Nutrition 
In a nutritionally deficient environment female flies lay fewer eggs, and when starved, 
after previously being well fed, the uptake of YPs ceases. This leads to a decrease in 
egg production which eventually stops; the oocytes no longer enter vitellogenesis and 
this causes a reduction in the number of mature eggs. 
Starved female Drosophila have reduced levels of yp mRNA in the fat body, 
however, this is not a general effect upon transcription rates because other genes, for 
example ci-tubulin, do not have their mRNA levels affected by starvation (Bownes a' 
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al., 1988). Control of yp transcript levels in the fat body does not seem to be 
mediated via the ovary; the presence or absence of vitellogenic ovaries has little effect 
on levels of yolk protein synthesis in the fat body (Bownes and Reid, 1990). The 
levels of ecdysone and juvenile hormone are similar in starved and fed flies, 
suggesting that these two hormones are not involved (Bownes, 1989). Both egg 
laying andyp gene transcription are resumed if the flies are returned to a protein-rich 
diet (Bownes and Blair, 1986). 
This response to a protein diet in Drosophila may be similar to the induction of 
vitellogenesis by protein rich food seen in other Diptera: Aedes (Raikhel ci' al., 1990), 
Musca (Adams and Gerst 1992, 1993) and Phormia (Zou ci' al., 1988). The biological 
significance of this food response in flies could be a mechanism for conserving 
components for egg development when food is limited, or a means of ensuring a food 
supply required by developing larvae. 
Several regions located within the 1226bp intergenic region of yp] and yp2 were 
shown independently of each other to confer nutritional regulation on the expression 
of ypi and yp2. These regions could interact with DNA binding proteins to provide 
the correct regulation of these genes, and nutrition may modulate the level of a trans-
acting factor in the fat body (Søndergaard ci' al., 1995). 
1.5.2 Hormones 
Juvenile hormone (JH) and ecdysone are two insect hormones which regulate 
moulting and metamorphosis, many experiments also indicate that these hormones 
are involved inyp gene regulation. 
The ability of ecdysone to regulate yp gene expression was first noted in abdomen 
isolation experiments, where levels of YP synthesis were low and could be increased 
by injection of 20-hydroxyecdysone (20E), the active form of ecdysone (Jowett and 
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Postlethwait, 1980). Injection of 20E into starved females produced a similar effect; 
the synthesis of YPs in the fat body, but not the ovary, appeared to increase 
(Bownes and Blair, 1986). The 20-hydroxyecdysone acts at the level of 
transcription, since in males it can initiate transient expression of the yp genes 
(Postlethwait et al., 1980). The expression is observed only in the fat body and not 
in any other of the adult tissues (Bownes et al., 1983), this will still occur in flies 
mutant in the sex determination pathway, and flies mutant in doublesex (dsx) or 
transformer (tra) can be induced to make YPs (Bownes and Nothiger, 1981). From 
analysis of the effects of 20E on various ypl, yp2 and yp3 reporter constructs, it 
appears that complex interactions occur between 20E response elements and 
repressor sites to produce the response to this hormone (Bownes et at, 1996). 
Juvenile hormone has also been implicated in the regulation of theyp genes. When the 
synthetic analogue of JH, methoprene, is applied topically to a female abdomen 
containing reduced yp expression levels, for example by isolating the abdomen or 
starvation, the level of transcripts increases (Jowett and Postlethwait, 1980). The 
level of yp transcripts from the fat body also increases with methoprene application 
in normally fed flies (Bownes et al., 1987). The effects of JH are subtle, resulting in 
stimulation of yp transcript levels up to twofold. Treatment with methoprene also 
leads to an increase in the level of yp transcripts in the ovary. However, since the 
methoprene stimulates uptake of yolk and the passage of oocytes through 
vitellogenesis, this effect could be due to genuine stimulation of yp gene expression or 
a consequence of the presence of vitellogenic oocytes leading to increased yp 
transcription. In experiments to test reporter gene constructs (containing various 
regions ofypl, yp2 and yp3) for their inducibility with methoprene, it was found that 
methoprene upregulation of YPs was only observed using native yp genes as 
reporters (Bownes et at, 1996). It was suggested that JH may act on intron 
sequences or yp coding sequences, or possibly by influencing stability of the yp 
mRNA. 
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A recent paper (Soller et al., in press) suggests that the balance between ecdysone 
and juvenile hormone regulates whether oocytes will progress through a control point 
at stage 9, or undergo apoptosis and resorption 
1.5.3 The sex determination hierarchy 
The sex of the fly is a primary factor in determining VP synthesis in Drosophila 
since YP expression is female-specific. The X chromosome to autosome ratio is the 
initial determinant of sexual phenotype. A ratio of 1 (XX:AA) results in female 
differentiation and a ratio of 0.5 (XY:AA) results in male differentiation. From 
genetic studies it is known that sexual dimorphism in Drosophila is governed by a 
hierarchy of somatic sex determination genes (reviewed in MacDougall et all, 1995; 
Ryner and Swain, 1995). Figure 1.5 shows diagrams of sex determination in female 
and male somatic cells. The X:A ratio acts to make the first gene in the hierarchy, 
Sex-lethal (Sxl), active in females or inactive in males. A number of maternally 
supplied and zygotic products are also required to initiate the correct activation of 
Sxl. Sxl has several critical functions in somatic cells, one of these is the repression, in 
females, of the male-specific lethal (msl) genes required in males for dosage 
compensation of X-linked genes. In males, which have only one X chromosome, 
these msl genes activate the genes on the X chromosome to become hyperactive, thus 
producing dosage compensation (Lucchesi and Maiming, 1987). The second major 
function of Sxl is the control of other regulatory genes in the sex determination 
pathway, including: transformer (tra), transformer-2 (tra-2), doublesex (dsx), 
intersex (ix) and hermaphrodite (her). When these genes are appropriately expressed 
they bring about the correct regulation of the downstream sexual differentiation 
genes, including the yp genes. 
In females, the Sxl transcript is spliced in a female-specific manner to produce a 
functional protein which then confers female-specific splicing of tra. This female- 
specific tra transcript produces a functional protein which, together with tra-2, 
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Figure 1.5 
Diagrams of sex determination in female and male somatic cells. 
X:A, X chromosome to autosome ratio; SXL, Sex-lethal transcript is spliced in female 
mode and makes a functional protein; TRA, transformer transcript is spliced in 
female mode in the presence of SXL protein and encodes a functional protein; TP.A-
2, transformer-2 product is required; DSX, doublesex transcript is spliced in female 
mode in the presence of TRA and TRA-2 proteins and makes a female-specific 
protein which regulates the expression of downstream genes; DSXM,  in the absence 
of TRA protein, doublesex transcript is spliced in the male mode to produce a male-
specifc protein which regulates the expression of downstream genes; IX, intersex 
product interacts with DSXF  to regulate downstream genes in females and affects 
courtship behaviour in males; HERzy6, the zygotic product of the hermaphrodite 
gene is required for female differentiation independently of DSX. S OV, the product 
of the small ovaries gene is essential for ovarian and female germline development. 
Arrows represent interactions shown experimentally. Arrows with question marks 
demonstrate possible interactions. 
(Adapted from MacDougall et at., 1995) 
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directs female-specific splicing of dsx. The female-specific dsx transcript produces 
the female form of Doublesex protein, DSXF,  which is functional (Burris and Baker, 
1989). In males, SW and Ira are spliced to generate non-functional proteins, since the 
mRNA open reading frames are truncated due to the inclusion of male-specific exons. 
This leads to the default splicing of the dsx transcript, which produces the functional 
male-specific Doublesex protein DSXM  (Burris and Baker, 1989). Also at the bottom 
of the dsx branch of the somatic sex determination hierarchy are the her (Pultz and 
Baker, 1995) and ix (Chase and Baker, 1995) genes. DSXF  acts together with her 
(Pultz and Baker, 1995) and ix (Erdman et al., 1996) gene products to inhibit male 
differentiation and activate female differentiation in females. Conversely, DSXM  acts 
to inhibit female differentiation and activate male differentiation in males (reviewed in 
Burtis, 1993). 
1.5.4 Genetic evidence for the control of yp gene expression by the sex 
determination genes 
Analysis of Drosophila Sxl, Ira, tra-2 and dsx mutants initially demonstrated that the 
genes in the sex determination hierarchy directly influence yp gene expression and 
subsequent YP synthesis (Postlethwait et al., 1980; Bownes and NOthiger, 1981). 
Chromosomally female flies (XX) that are mutant at tra or tra-2 do not express the 
yp genes and develop morphologically as males, these are termed pseudomales. 
Chromosomally female flies mutant at dsx develop as intersexes and display both 
male and female characteristics, these express the YPs at levels reflecting the degree 
of male or female characteristics displayed, for example flies with a predominantly 
male phenotype have the lowest levels of YP expression. Chromosomally male flies 
(XY) mutant at dsx also develop as intersexes and are able to express the YPs in the 
fat body. 
In the fat body, the correct yp expression pattern is continuously dependent upon 
the correct expression of the somatic sex determination genes. This can be 
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demonstrated with experiments using tra_21S  (temperature sensitive) mutants (Belote, 
etal., 1985). XX tra_2tS  flies are female when reared at 16°C, but are transformed into 
pseudomales when reared at 29°C. The female flies reared at 16°C express the YPs in 
the fat body, if these flies are shifted to 29°C their YP expression becomes repressed. 
Returning the flies to 16°C restores the expression of YPs in the fat body (Bownes et 
al., 1987). 
To determine if the somatic sex determination genes are required for ovarian yp gene 
expression, XX tra_2tS  flies were reared at 16°C to give females and then shifted to 
29°C, at this restrictive temperature YP synthesis continued in the ovarian follicle 
cells. Despite YP expression being repressed in the fat body at 29°C, the ovaries can 
synthesise enough YPs to produce a few mature oocytes (Bownes et al., 1990). Thus 
ovarian yp gene expression is not under the continuous control of the sex 
determination genes, but depends upon tissue-specific factors, perhaps expressed in 
the follicle cells. The sex determination genes are necessary to determine the 
development of the ovaries in females, but once formed, they are no longer required 
to monitor sex-specific gene expression in the mature tissue. 
Recently a paper has been published showing that her is a regulator of yp gene 
expression (Li and Baker, 1998). Temperature sensitive her' mutants were used in 
the experiments, raised at 18°C they are morphologically normal and have wild type 
viability, and raised at 25°C they are intersexual and have severely reduced viability 
(Pultz et al., 1994). her females raised at 25°C show a 10-fold reduction of yp 
transcript levels compared to wild type females and their her' 1+ sisters. These 
results were comparable to those obtained with dsx mutant females. The level of w 
transcript can be restored to wild type levels in her mutant females raised at 25°C 
when they carry a transgene containing a wild type copy of the her gene. In her 
males, the yp transcript level remains unchanged, this is in contrast to dsx males 
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where the yp level is increased 20-fold compared to that of wild type males and dsx/+ 
brothers. It is proposed that HER protein is required, like DSXF,  for the activation of 
the yps in female fat body cells. But, in contrast to DSXM,  HER is not required for 
the inhibition of yp expression in males. 
1.5.5 Trans-acting factors regulating the yps in the fat body 
The 125bp FBE from the intergenic region of yp] and yp2 has been used in 
footprinting assays to identify several transcriptional regulatory proteins implicated 
in the control of fat body-specific yp gene expression. These transcriptional 
regulatory proteins are: the adult enhancer factor-i (AEF-1), the box B-binding 
factor-2 (BBF-2) and the CCAAT/enhancer-binding protein (C/EBP). Initially, these 
proteins were found to interact with the adult enhancer of the alcohol dehydrogenase 
(Adh) gene in Drosophila to control Ad/i gene expression in the adult fat body. 
BBF-2 is a member of the CREB/ATF family of transcriptional regulatory proteins 
and is an activator of Adh gene transcription in the Drosophila fat body (Abet et al., 
1992). C/EBP is a transcriptional activator of the Ad/i gene originally identified in rat 
liver cells, and a member of the bZIP family of transcription factors, the Drosophila 
homologue of this protein (DrnC/EBP) has been identified and is encoded by the slow 
border cells (slbo) gene (Montell et al., 1992). AEF-i was isolated from Drosophila 
and found to inhibit the binding of CIEBP, the AEF- 1 binding site is thought to 
function as a negative regulatory element for the Adh gene in Drosophila (Falb and 
Maniatis, 1992b). These three proteins were found to have binding sites within the 
FBE of ypi and yp2 (Abel et al., 1992; Falb and Maniatis, 1992a), such that C/EBP 
and AEF-1 have overlapping recognition sites (Figure 1.6). They are thought to bind 
competitively creating a possible activation (C/EBP)/repression (AEF-i) mechanism, 
since AEF-i can inhibit binding of C/EBP and thereby repress its activating potential 
(Falb and Maniatis, 1992a). It should be noted that the effects of these proteins on 
yp gene expression in vivo are unknown. 
25 
CHAPTER ONE: INTRODUCTION 
Figure 1.6 
Diagram to show the FBE sequence and the locations of various transcription factor 
binding sites within this sequence. 
The FBE of ypi and yp2 (Garabedian et al., 1986) is located between nucleotide 
positions -196 and -323, relative to the ypl transcription start site. The symbols 
superimposed on the FBE sequence identify the sequences protected from DNaseI 
digestion by the corresponding transcription factors shown. 
Footprint sequences for the transcriptional regulatory proteins AEF-1, CIEBP and 
BBF-2 (Abel et al., 1992; Falb and Maniatis, 1992a, 1992b) and four DSX binding 
sites (Burtis et al., 199 1) are shown. 
Nucleotide positions are given relative to the ypi transcription start site. 
AEF-1 DSX A C/EBP 	DSX B DSX B 	 DSX C BBF-2 





_ ___ _ 
-312 	-303 	-295 	-284 -232 	-222 
The two forms of Doublesex protein, DSXM  and DSXF,  have been shown to bind to 
four sequences in the 125bp FBE of ypl and yp2 (Burtis et al., 1991). Three 
footprints, named A, B and C, were identified in binding assays with the FBE and 
DSXM and  DSXF.  The footprints identified for DSXM  were indistinguishable from 
those identified for DSXF,  these binding sites are shown in Figure 1.7. Footprint A 
was found to have the highest affinity for the DSX proteins, and footprint C has the 
least. A comparison of the three footprints revealed a potential 9bp consensus 
recognition sequence, CTACAAAGT. Four sequences within the binding sites match 
this consensus, with two copies occurring in the larger footprint B, indicating that it 
may be composed of two binding sites. The homologies of each binding site to the 
consensus sequence is shown in Figure 1.7. It can also be seen that the consensus 
sequences are located at similar positions within the binding sites, four nucleotides 
from the 5' ends and five to six nucleotides from the 3' ends of the footprints. The 
location of the four DSX binding sites, in relation to the binding sites of AEF-1, 
C/EBP and BBF-2, are shown in Figure 1.6. Footprint A overlaps with the shared 
AEF- 1 and C/EBP binding sites and footprint C overlaps with the BBF-2 binding 
site. If one site contains AEF- 1 and C/EBP binding sites to confer fat body-
specificity and DSX binding sites to confer the sex-specificity of yp] and yp2 
expression, this could explain why the sex- and fat body-specificity of yp gene 
expression has never been separated in the reporter constructs used to identify the 
FBE. 
The DSXM  and DSXF  proteins can provide a mechanism for conferring sex-
specificity. Sex-specific dsx transcripts produced by alternate splicing encode DSX 
proteins with identical N-termini comprising of 397aa, and sex-specific C-termini of 
either 152aa (DSXM)  or 30aa (DSXF).  The N-terminal region common to both 
proteins contains a zinc finger-related DNA binding domain (Erdman and Burtis, 
1993), and thus the DSXM  and DSXF  proteins have the same binding sites within the 
FBE in vitro. The sex-specific C-termini of the DSX proteins could confer sex- 
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Figure 1.7 
The four protected footprint sequences from binding of DSX proteins to the FBE of 
yp] and yp2 (adapted from Burtis et al., 1991). Homologies to the proposed 
consensus binding sequence are underlined and the first nucleotide positions 
indicated. The number of matched nucleotides to the consensus in each footprint are 
also given. 
Footorint 	 Protected Sequence 	 Match 
191011, 
A 	 ACAACTACAATGTTGCAAT 	 8/9 
-279 	 -268 
B 	GAGCCTACAAAGTGATTACAAATTAAAATA 	9/9 7/9 
-235 
C 	 GGTGCTGCTAAGTCATCA 	 7/9 
specific expression of their target sex differentiation genes by causing different 
interactions between regulatory factors for these genes and DSXM or DSXF . 
The DSXM  and  DSXF  proteins were found to directly link the sex determination 
pathway and the sex-specific transcriptional regulation of ypi and yp2 via the 125bp 
FBE (Coschigano and Wensink, 1992). Mutating the A and B dsx-binding sites 
within the FBE substantially reduces binding by both DSX proteins in vitro and also 
eliminates almost all of the sex-specific regulation by the FBE in vivo. Using dsx 
mutants, it was also demonstrated that both DSXM  and  DSXF  require the A and B 
dsx-binding sites to regulate the sex-specificity of transcription in vivo. Both DSX 
proteins were found to bind to the same sites in the FBE, but they have opposite 
effects on reporter gene transcription. DSXM  was found to be strong repressor of 
transcription and DSXF  activates transcription. The observation that DSXM  represses 
transcription is consistent with previous genetic results, which showed that in the 
absence of DSX proteins, YPs were expressed, but the presence of DSXM  yp gene 
expression was repressed (Bownes and Nöthiger, 1981). In contrast, the observation 
that DSXF  activates FBE-directed transcription is inconsistent with the simplest 
interpretation of previous genetic results: that DSXF  is a repressor of male specific 
genes (Baker and Ridge, 1980). Although these experiments have demonstrated the 
role of DSXM  and DSXF in linking the sex determination pathway to target gene 
regulation, it is possible that the DSX proteins act in conjunction with one or more 
other proteins to accomplish the observed fat body and sex-specific yp gene 
regulation. 
Further experiments investigating the FBE-directed regulation of ypi and yp2 
identified a simple sex- and tissue-specific enhancer from within the FBE sequence 
(An and Wensink, 1995a). This enhancer, named o-r, is organised into two enhancer 
elements, o and r. The o element contains overlapping binding sites for DmC/EBP 
and the two DSX proteins. In the o element these binding sites are referred to as: 
bzipl and dsxA, with bzipl being the binding site of DmC/EBP. This element 
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corresponds to the highest affinity DSX footprint A overlapping with the shared 
AEF-1 and CIEBP binding sites previously mentioned (shown in Figure 1.6), but the 
AEF-1 binding site (aefi) was not included because mutations in aefl were found to 
have no effect on the sex-and tissue-specific enhancer o-r. The r enhancer element is 
proposed to contain a binding site, named refl, for an unidentified positive regulatory 
factor. The elements 2  and £ have no enhancer activity by themselves, but when 
combined are sufficient for the tissue- and sex-specific expression observed with the 
whole FBE. The o-r enhancer was characterised by site-directed mutagenesis, protein 
binding and germ line transformation experiments, to propose the following model. 
A two-level model is proposed for regulation by o-r (An and Wensink, 1995a). At 
the first level, tissue-specific activation in fat bodies requires strong co-operative 
activation by two proteins, one bound to refl and the other bound to bzip I. At the 
second level, DSX proteins at dsxA modify this tissue-specific activation by their 
effect on a bZIP protein at bzip I. In females, DSXF  activates indirectly by keeping 
an active bZIP protein at the bzipl site. It may do this by either increasing the 
activity of the bound protein or by increasing the binding between the bZIP protein 
and the bzipl site. In males, DSXM inactivates by blocking the synergy between 
bzipl and ref 1, it does this by reducing the activity of the bZIP protein at the bzipl 
site. A mechanism for DSXM  to achieve this is by sterically hindering the binding of 
bZIP or by inactivating this protein. If steric hindrance is involved, DSXF  may not be 
capable of excluding bZIP binding to bzipl in females due to its shorter C-terminus 
compared to DSXM  (Burtis and Baker, 1989). 
The exception to this model is the activation seen in female fat bodies when bzipl is 
mutated. It is speculated that DSXF  gives sufficient activation to bZIP despite the 
lower affinity of the mutated bzipl site. There is no evidence that DmC/EBP is a 
regulator of yp] and yp2 gene expression, nor have any DmC/EBP transcripts been 
identified in adult fat bodies (Rørth and Montell, 1992), the DmC/EBP binding site is 
called bzipl because the bZIP protein actually activating from this site is unknown. 
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1.5.6 Recent models proposed for the female, fat body regulation of ypl and 
yp2 
An and Wensink (1995b) investigated the o-r enhancer further, and in these 
experiments, an o element was used that contained the aefi site which binds AEF-1 
protein. A tetramer of the o enhancer element is found to be sufficient to activate 
female-specific reporter gene transcription in fat bodies. This shows that the dsxA, 
bzip 1 and aefi sites can be sufficient to direct the yp gene expression pattern, but 
require arrangement into a tetramer to be capable of doing so. A tetramer of the r 
element was found to direct reporter gene expression in all nongonadal tissue, and 
thus, is not responsible for either the sex or fat body-specificity of o-r. Mutated 
binding sites within the o tetramer were used in protein binding, germ line 
transformation and genetic experiments to examine both the independent and 
combined activities of the proteins and their binding sites. This led to the proposal of 
another model for the regulation of ypl12 by the o-r enhancer, a summary diagram is 
shown in Figure 1.8. 
In this model, in female fat bodies there is synergism between DSXF  and bZIP 
activator possibly by co-operative binding or by altering bZIP activity upon its 
binding to the site. The bZIP also acts cooperatively with an activator at the refl site 
to yield gene expression in the female fat body. The ability of bZIP proteins to 
interact with other transcriptional factors has been well documented (for review, see 
Nolan, 1994). The second positive transcriptional effect of DSXF  in female fat bodies 
is to interfere with the binding of AEF-1 and thus prevent it repressing transcription. 
In male fat bodies, DSXF  is not present and therefore prevents the bZIP activator 
from binding co-operatively. Instead, DSXM  is present and binds to the dsxA site, 
because the DSXM  protein has a bulkier male-specific carboxy-terminal domain it can 
sterically hinder activation by bZIP protein. Alternatively, bZIP may be inactivated 
by DSXM ,  this is not shown in Figure 1.8. The elimination of bZIP activation 
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Figure 1.8 
Model for transcriptional regulation by o-r. 
Top 
Activation in female fat bodies resulting from synergy among the DSX, bZlPa and R 
proteins. Curved arrows indicate activation, and the arc between bZIPa and R 
repesents positive cooperativity. These three proteins are shown bound to their 
cognate sites on o-r DNA (solid lines). The AEF- 1 repressor is shown unbound, 
excluded from its DNA site by DSXF.  Broken lines represent DNA between o-r, and 
the promoter (right angle arrow). 
Middle 
Repression in male fat bodies resulting from DSXM .  DSXM is shown bound to DNA, 
excluding the other two proteins from binding. 
Bottom 
Inactivation in ovaries and tissue specificity. The absence of dsx proteins allows 
AEF- I to bind, excluding activators from the bZIP site. The bZIPa and bZIPb 
proteins activate from the bzipl site but have different tissue distributions. 
(adapted from An and Wensinlc, 1995b) 
FEMALE 
FAT BODY 
aef- 1 	dsxA bzip 1 	 refi 
MALE 
FAT BODY 
aef-1 	dsxA bzipl 	 ref] 
OVARY 
	 AEF-1 I 
aef-1 	dsxA bzipl 
	 ref 1 
removes synergy with an activator at the ref 1 site and will not yield gene expression 
in the male fat body. It is thought that AEF-1 is unlikely to repress in male fat bodies 
through o-r because of steric hindrance by DSXM 
In ovaries it is proposed that due to the absence of DSX proteins, the AEF- 1 
repressor binds and excludes activators from the bZIP site. The bZIPa and bZIPb 
(proposed tissue-specific bZIP in the ovary) activate from the bzipl site but have 
different tissue distributions. 
Another paper has been published recently, Li and Baker (1998), describing the role 
of the hermaphrodite (her) gene and dsx in the regulation of the yps. It is proposed 
that they control the expression of the yp genes in the fat body by two separate 
pathways for the activation of the yps. One pathway is the female-specific activation 
of the yps, which is DSXF  dependent. The other pathway is the non-sex-specific 
activation of the yps, which is HER-dependent, DSXFindependent  and inhibited by 
DSXM .  The combination of these effects, in wild-type females, results in both HER 
and DSXF contributing independently to produce high level expression of the yps. In 
wild-type males, DSXM  inhibits yp expression, which can override the activation 
function of HER. The 125bp FBE of ypi and yp2 (position -196 to -322) was not 
found to be sufficient to confer her responsiveness, and the major her responsive 
element is located outside of FBE. HER is a zinc finger protein and is thought to 
regulate the yps directly. The her responsive region, termed HRR, is located between 
nucleotide positions -322 to -1225 in the intergenic region of ypi and yp2. The fat 
body-specific expression of the yps is not specified by dsx since, in dsx mutant flies 
of both sexes, the expression of yp-reporter genes is still restricted to fat body cells. 
HER is also not considered to be necessary for fat body-specific expression of the 
yps because loss of her does not affect fat body-specific expression of a transgene, 
and the FBE-reporter construct can confer fat body-specific expression without the 
HRR present. An unknown fat body-specific factor, termed FBF, binding possibly 
to the bZIP site in the FBE is thought to confer tissue-specificity to the fat body 
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only. The HRR is necessary for her function but is not thought to be sufficient for yp 
expression, it is deemed likely that the FBF is also necessary for HER to direct the 
yps. Besides her and dsx, the intet-sex (ix) gene also acts in the dsx branch of the sex 
determination pathway. It has been observed that ix is also required for the 
transcriptional activation of the yp genes in females, but is not required for their 
repression in males. Genetic studies indicate that ix interacts with her and with dsx in 
regulating the yps in females (Baker, unpublished data). It is thought that ix may 
participate both in the HER-dependent non-sex-specific activation pathway and in 
the DSXF_dependent female-specific activation pathway. It is postulated that a 
candidate DNA site in the FBE through which IX might function is the "refi" site, 
shown to synergistically function with the DSX binding site, dsxA (An and Wensink, 
1995b). 
Considerably more research is required in this area in order to fit these two models 
together and determine exactly how ypl and yp2 are regulated in the female fat body. 
It should also be noted that the FBE is not the only sequence within the intergenic 
region of ypi andyp2 capable of conferring female, fat body expression. The FBE can 
be deleted without preventing female, fat body yp expression, thus suggesting there 
are more sites to be located. 
1.5.7 Trans-acting factors regulating the yps in the ovary 
No regulatory proteins have yet been identified for the direction of yp tissue-specific 
ovarian expression. For ypi and yp2, the mechanism of ovary-specific regulation is 
likely to be complex to resolve due to these genes having shared promoter sequences 
in the intergenic region, and there being two enhancers, OE 1 and 0E2, required for 
correct ovarian yp expression. For yp3, a 328bp ovarian enhancer (0E3) has been 
found to bind in gel retardation assays to a protein present in ovarian nuclear 
extracts, but the identity of this protein is unknown (E. Ronaldson, unpublished 
data). 
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Several years ago, the yolk protein factor 1 (YPF1) protein was isolated from tissue 
culture cells (KcO cells, an embryonic cell line derived from first instar larvae), and 
was also found to be present in ovarian and early embryonic extracts. YPF1 was 
thought to be a potential regulatory factor for ovarian yp expression because it was 
found to bind to a 31bp sequence located within the ypi coding sequence, close to the 
transcription start site (Mitsis and Wensink, 1989a; 1989b). Computer sequence 
comparisons revealed a similar sequence (21/31bp match) in a position in yp3. 
However, since this was in the yp3 coding sequence it is not known if the similarity 
is for YPF1 binding or a requirement for the structure or function of the yolk 
proteins themselves. Deletion of the binding site was found to reduce ypl transcript 
levels (Mitsis and Wensink, 1989b), but this could have been due to transcript 
instability instead of the loss of binding by a transcriptional activator protein. YPF1 
has now been identified as a Drosophila homologue of the small (70 kDa) subunit of 
the heterodimeric Ku DNA-binding protein, a human DNA-dependent protein kinase 
(Jacoby and Wensink, 1994). Ku and YPF1 are thought to be involved in the 
initiation of transcription, and could be involved in bringing about high levels of yp 
transcription during oogenesis. YPF1 is expressed at low levels throughout 
Drosophila development, with high levels of transcripts found in the oocyte and 
early embryo, which is consistent with the proposed function for YPF1. It is 
unlikely that YPF1 has a specific role in regulating ypi gene expression in the ovary, 
but is more likely to have a general role in transcription initiation. 
Genetic experiments have demonstrated that ovarian yp expression is not under the 
continuous control of the sex determination hierarchy, and it is therefore presumed 
that yp expression in the ovary depends upon tissue-specific factors, expressed in the 
follicle cells. It is possible that factors regulating fat body-specific expression of the 
yps could also be regulators of ovarian yp expression, however, this is entirely 
speculative. 
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1.6 THE YOLK PROTEIN GENES IN OTHER DIPTERAN INSECTS 
In addition to Drosophila melanogaster, yolk protein encoding genes have also been 
isolated from the Mediterranean fruit fly Ceratitis capitata (Rina and Savakis, 1991), 
the bluebottle Calliphora aythrocephala (Martinez and Bownes, 1994) and the 
common housefly Musca don-iestica (White and Bownes, 1997). Compared with 
Drosophila yolk proteins, their expression profiles and polypeptide sequences are 
highly conserved. The restriction of yp expression to the adult female fat body and to 
the follicle cells at specific stages of oogenesis is conserved in all these species. Thus, 
it seems possible that the yp genes in these species share conserved regulatory 
sequences and mechanisms to achieve a similar pattern of gene expression. 
To study conservation of yp regulation in dipteran insects, 5' flanking regions from 
one Muscayp gene and one Calliphora yp gene were tested for enhancer functions in 
Drosophila (Tortiglione and Bownes, 1997). A 823bp fragment from Musca and a 
1 046bp fragment from Calliphora yp genes are able to direct correct expression of a 
reporter gene in the ovarian follicle cells of transformed Drosophila. Reporter gene 
expression was also observed in the border cells, in contrast to the endogenous host 
Drosophila yp genes. This suggests that a repressor of border cell expression has 
evolved in Drosophila, although the reason for this happening is unknown. These 
fragments are unable to confer sex-specific reporter gene expression in the fat body, 
and expression was observed in the fat body cells of both males and females. This 
suggested that in Drosophila, DSX protein (diverged during evolution) would not 
recognise the enhancer binding sites between species, or by another mechanism. 
However, by in vitro DNA/protein interaction assays, a 248bp DNA region from the 
Musca yp enhancer was able to bind specifically to the Drosophila DSX protein, 
which in Drosophila directs the sex-specific expression ofypl and yp2. It is therefore 
speculated that in Musca and Calliphora adult females, the sex determining pathway 
is not directly involved in yp regulation, but instead hormonal controls are used to 
achieve the sex-specific expression of theyp genes. 
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One aspect of development which is different between the species is the synchrony 
of oogenesis. In the more primitive species, a batch of eggs develops synchronously 
after feeding, whereas in Drosophila eggs of all stages are present in the ovaries of fed 
flies (King, 1970). In Calliphora and Musca, the fat body produces YPs in cycles 
related to feeding (Adams and Gerst, 1992; 1993). 
1.7 THE REGULATION OF YP3 EXPRESSION IN DROSOPHILA 
Although the regulation of ypi and yp2 gene expression has been investigated in some 
detail, very little is known about the regulation of yp3 in the ovary and the female fat 
body. For yp3, two cis-acting sequences, located 5' of the transcription start site, 
have been found to direct ovarian and sex-specific fat body expression of the 
Drosophila yp3 gene. A 328bp ovarian region (OE3) is sufficient to limit reporter 
gene expression to the correct follicle cell types at the expected stages 8-10 of 
oogenesis., and an adjacent 419bp sequence, termed FBE3, is able to direct reporter 
gene expression, from a heterologous promoter, in the fat body cells of females, but 
not males (Ronaidson and Bownes, 1995). 
Genetic analysis has shown that the sex-specificity of yp3 expression is under the 
control of the sex determination hierarchy (Bownes and Nöthiger, 1981; Li and 
Baker, 1998), but no investigations into the direct binding of DSX or HER proteins 
with yp3 sequences have been reported. Due to the expression patterns of ypi, yp2 
and yp3 being so highly co-ordinated, it is likely that the factors involved in the 
transcriptional regulation of all three yp genes are the same, or very similar. The cis-
acting sequences involved in regulating yp3 expression may be less complex than 
those shared between the divergently transcribed yp] and yp2. 
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The aim of this PhD project was to further characterise the FBE3 and 0E3 sequences 
by dividing them into subfragments and testing their ability to direct reporter gene 
expression in the correct yp3 expression pattern. Also to identify trans-acting factors 
involved in directing yp3 gene expression in the ovary and the fat body. The trans-
acting factors involved in yp] and yp2 are also candidates for the regulation of yp3, 
therefore, comparisons can be made between the factors involved in the regulation of 
all three yolk protein genes. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 MEDIA 
2.1.1 Bacterial Media 
All media were made up in distilled water and sterilized by autoclaving 
(1 5psil20rnins). Ampicillin was added to media and plates to a final concentration of 
I 00.tg/ml when required. 
Luria Broth (LB) 	lOg Difco Bacto Tryptone, 5g Difco Bacto Yeast Extract, 5g 
NaCl. Made up to 1 litre with H 20 and adjusted to pH 7.2. 
Luria Agar 	As LB with the addition of 15g Difco Bacto Agar per litre. 
2.1.2 Drosophila Media 
Staffan Food 	250g cornflour, 175g yeast pellets, lOOg agar dissolved in 10 
litres H20 and boiled. Nipagin was added to 4.5igIl when 
cooled to 60°C and the food was then poured into bottles and 
vials. 
Apple Juice Media 	9g Difco Bacto Agar and 1 O sucrose was dissolved in 300ml 
H20 by microwaving, lOOmI apple juice was added when the 
solution had cooled to 60°C and the media was poured into 
petri dishes. 
Tomato Juice Media 4g Difco Bacto Agar was dissolved in 165m1 F1 20 by 
microwaving, 40ml tomato juice and 0.5m1 10% Nipagin was 
added when the solution had cooled to 60°C and the media 
was poured into petri dishes. 
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2.2 BACTERIAL, PLASMJ]) AND DROSOPHILA STOCKS 
Table 2-1: Bacterial Stocks 
Cell Type Genotype Reference 
XL1-Blue recAl, 	endAl, 	gyrA96, 	thi-1, 	hsdRl7, Bullock, Fernandez and 
supE44, 	relAl, 	lac[F' 	proAB, Short, 1987 
lac"ZNvI]5, Tn 10 (tel')] 
BL21(DE3) F-, 	ompT, 	hsdS8, (rB-,ma-), dcm, gal, Studier and Moffat, 1986 
X(DE3) Davanloo et al., 1984 
Table 2-2: Plasmids for subcloning 
Plasmid Genotype Comments Reference 
pBluescript Amp' Vector used for subeloning 
yp3 sequences 
Stratagene 
Table 2-3: Plasmids for P-element mediated germ line transformation 
Plasmid Genotype Comments Reference 
pERT Amp' Used 	to 	test 	the 	effects 	of yp3 Ronaldson 	and 
constructs lacking the yp3 promoter on Bownes, 1995 
lacZ reporter gene expression 
pA2-3 Amp' Helper 	plasmid 	for 	P-element 
transformation, encodes transposase 
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Table 2-4: Plasmids containing subclones used in this work 
Plasmid Genotype Comments Reference 
pGEX-KG Amp' GST-DSX binding domain Erdman and Burtis, 1993 
fusion protein expression 
vector 
bs435 Amp' pBluescript SK containing T. Maniatis, personal 
AEF-1 cDNA communication 
DmC/EBP Amp' pT5 expression vector Rorth and Monte!!, 1992 
containing DmC/EBP 
yp3/9 Amp' 419bp FBE3 fragment in E. Rona!dson, personal 
pB!uescript communication 
yp3/5 Amp' 328bp 0E3 fragment in E. Rona!dson, personal 
pCaSpeR-AUG-gal vector communication 
pGEM YPIA Amp' pGEM vector containing yp] 
pOEM YP2B Amp' pGEM vector containing yp2 
pOEM YP3 Amp' pGEM vector containing yp3 
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Table 2-5: Drosophila stocks 
Name Relevant Features Reference 
Oregon R (OrR) A Drosophila melanogaster wild 
type strain 
Lindsley and Gre!!, 1968 
wr white- (white eyed) 
1(2)s1b0' 7" slbo deletion, homozygous lethal Monte!l et al., 1992 
fs(2)s1bo'' 8 rosy+ insertion, female sterile Montell et al., 1992 
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2.3 OLIGONUCLEOTIDES 
Oligonucleotides were obtained from Oswel and were supplied dissolved in -1m1 
sterile distilled water. Oligonucleotides used are detailed in Table 2.6. 
Table 2-6 Oligonucleotides used in this work 
Name Sequence 5' to 3' 	 1 Description 
T3 AAT TAA CCC TCA CTh AAG General sequencing primer 
GG  
T7 GTA ATA CGA CTC ACT ATA General sequencing primer 
GGGC  
Adh ATC GAA AGA 0CC TGC TAA pERI sequencing primer 
AGC  
White TTC AAT GAT GTC CAG TGC pERI sequencing primer 
AG  
825X TTTCCC TTG ACT TGC ACTT PCR 	amplification of 	150bp 
0E3 fragment 
826X TCG CGTGAC GGTCGC TAA PCR 	amplification 	of 	150bp 
0E3 fragment 
P4048 GGA ATT CAA GGG ATC TGC PCR 	amplification 	of 246bp 
ACA AGT TG FBE3 subfragment 
P4049 GGA ATT CAA CCT CTT CAC PCR 	amplification 	of 246bp 
ACT TOG C FBE3 subfragment 
CEBPRF2 CGA TGC CGT TCA GAC ATT DmC/EBP forward primer 
W2495 GG  
CEBPRR2 ATG TCG CTG AAG ATG CCC DmC/EBP reverse primer 
W2496 AG  
P5699 GTG CAC AAC TAC AAT GTT FBEypI/2: -312 to -284 
GCA ATC AGC GG coding strand 
P5700 CCG CTG ATT GCA ACA TTG FBEypI/2: -312 to -284 
TAG TTG TGC AC I non coding strand 
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2.4 SOLUTIONS 
Chemicals were obtained from Sigma, BDH, Aldrich, Fison 
Radioisotopes [32]dCTP and [355]dATP, and Hybond-C were obtained from 
Amersham. 
Enzymes were supplied by Boehringer Mannheim, Gibco BRL, NBL, NEB, 
Pharmacia, Promega or USB. 
Digoxygenin labelling and detection kit was purchased from Boehringer Mannheim. 
Standard solutions were made using sterile distilled water and sterile, baked 
glassware. Most solutions were sterilized by autoclaving (15psil15min) or by 
passing through a 0.45 gm nitrocellulose filter. 
TAE 	 40mM Tris-acetate, 1mM EDTA, pH 7.8 
TBE 	 89mM Tris-HCI, 89mM boric acid, 2.5mM EDTA, pH 8.3 
TE 	 10mM Tris-HC1, 1mM EDTA, pH 8.0 
i OX DNA Loading Buffer 
0.25% Bromophenol Blue, 0.25% Xylene Cyanol FF, 30% 
glycerol in H20. 
PBS (phosphate buffered saline) 
8g NaCl, 0.2g KCI, 1.44g Na2HPO4, 0.24g 1CH 2PO4 dissolved 
in 800ml H20, pH adjusted to 7.4, made to 1 litre and 
sterilized by autoclaving. 
PBT 	 PBS with 0.1% (vlv) Tween-20 
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Ringer's Solution 	6.5g NaCl, 0.14g KCI, 0.2g NaHCO 3 , 0.12g CaC12, 0.019 
NaH2PO4 per litre, sterilized by autoclaving. 
2.4.1 Competent Cell Solutions 
TSS 	 10% (w/v) PEG (Mr 3350 or 8000), 20-50mM MgC12 in LB 
media. pH adjusted to 6.5-6.8 and filter-sterilized. An aliquot 
of DM50 was added to give a final concentration of 5% (vlv) 
and the solution was stored at 4°C. 
TFB 1 	 30mM potassium acetate, 10mM CaCl 2, 50mM MnCl2 , 
100mM RbCI, 15% glycerol. pH adjusted to 5.8 with 1M 
acetic acid. Filter-sterilized and stored at room temperature. 
TF132 	 10mM MOPS or PIPES (pH 6.5), 75mM CaC1 2, 10mM 
RbC1, 15% glycerol. pH adjusted to 6.5 with 1M KOH. 
Filter-sterilized and stored at room temperature. 
2.4.2 DNA Preparation Solutions 
P1 	 3.03g Tris, 1.86g EDT&, pH adjusted to 8.0 and made up to 
SOOml. Stored at 4°C. 
P2 	 200 jil 10M NaOH, lml 10% SDS, volume adjusted to lOmI. 
Made fresh each time used. 
P3 	 147.23g potassium acetate dissolved in 250m1 H 20, adjusted 
to pH 5.5 with glacial acetic acid (approximately 55m1), made 
up to 500m1 with H2O. Stored at 4°C. 
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TGE 	 50mM glucose, 25mM Tris (pH 8.0), 10mM EDTIA (pH 8.0) 
2.4.3 Sequencing Gel Solutions 
Sequencing Gel Acrylamide Stock 
Long RangerTM (AT Biochem), 50% acrylamide stock 
solution 
6% Sequencing Gel Solution 
21g Urea, 3m1 lOx TBE, 6m1 Long Ranger dissolved by 
warming gently, then cooled and made up to SOml with 
deionized water. Polymerised with 250R1  10% LAPS and 25j.fl 
TEMED. 
2.4.4 Protein Gel Solutions 
2x Polypeptide Sample Buffer 
1.25m1 1M Tris-FIC1 pH 6.8, 2m1 glycerol, 5m1 10% SDS, 
0.5m1 0.1% Bromophenol Blue. Made up to 9m1 with H 20, 
then added lml 2-mercaptoethanol. 
Protein Gel Acrylamide Stock 
Protogel (National Diagnostics) 30% acrylamide solution, 
2.7% crosslinked with methylene bisacrylamide (37.5:1 
ratio), in distilled H20. 
10% Separating Gel Solution 
6.66m1 Protogel, 2.5m1 3M Tris pH8.8, 200111 10% SDS, 
10.42m1 H20. Polymerised with 200111 10% LAPS and 20j.tl 
TEMED. 
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4% Stacking Gel Solution 
650p1 Protogel, 650i.fl 0.5M Tris pH6.8, 50111 10% SDS, 
3.59m1 1120. Polymerised with SOp.! 10% APS and 10111 
TEMED. 
lOx Running Buffer 	30g Tris, 144g glycine, lOg SDS. Made up to 1 litre with 
1120. 
2.4.5 Protein Purification Solutions 
Z-100 	 100mM KCI, 25mM HEPES p117.9, 12.5mM M902, 1mM 
DTT, 0.1% NP-40, 10% glycerol, 1mM PMSF 
Z-50 	 50mM KCI, 25mM HEPES pH7.9, 12.5mM M902, 1mM 
DTT, 0.1% NP-40, 10% glycerol, 1mM PMSF 
2.4.6 Bradford Assay Solutions 
0.5 mg/ml bovine serum albumin (BSA) 
the concentration of BSA is determined using the A 280 = 6.6 
for a lomglml solution of BSA (1cm pathlength). 
Coomassie Brilliant Blue Solution 
100mg Coomassie Brilliant Blue G250 was dissolved in 50m1 
of 95% ethanol. lOOmI 85% phosphoric acid was added and 
the solution was made up to 1 litre with H20. The solution 
was then filtered through Whatman No. 1 filter paper and 
stored at 4°C. 
45 
CHAPTER TWO: MATERIALS AND METHODS 
2.4.7 0-galactosidase Staining Solutions 
X-gal Stock 	8% (w/v) 5-bromo-4-chloro-3-indony1-3-galactosidase, made 
up in dimethyl formamide and stored in a dark container at 
-20°C. 
X-gal Staining Buffer Solution A 
0.5M Na2HPO4/NaH2PO4 
cnh11tnn p 
10mM Solution A, 150mM NaCl, 1mM MgC12, 7mM 
Potassium Ferrocyanide, 7mM Potassium Ferricyanide. 
Stored in a dark container at 4°C. Immediately prior to use, 
X-gal was added to a concentration of 0.2% (wlv). 
2.4.8 Gel Retardation Assay Solutions 
5X Tris-glycine 	30.28g Tris, 142.7g glycine, 3.92g EDTA. Made up to 1 litre 
with H20, approximately p11 8.5. 
High Ionic Strength Gel Mix 
6ml 5X Tris-glycine, 4.8m1 Protogel, 1.5m1 50% glycerol, 
17.7m1 H20. Polymerised with 250p.l 10% APS and 34p1 
TEMED. 
5X Z-50 Incubation Buffer 
250mM KC1, 125mM HEPES pH7.9, 62.5mM M902, 5mM 
DTT, 0.5% NP-40, 50% glycerol, 5mM PMSF 
High Ionic Strength Electrophoresis Buffer 	 1X Tris-glycine 
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5X Gel Shift Loading Buffer 
8m1 5X Tris-glycine, 2m1 glycerol, 0.01g Bromophenol Blue. 
2.4.9 Western Blot Solutions 
Transfer Buffer 	25mM Tris pH 8.3, 192mM glycine, 20% methanol 
Ponceau S Staining Solution 
20ml Ponceau S Concentrate (Sigma) mixed with 1 80m1 
deionised water, stored at room temperature. 
2.4.10 HRP Western Detection Solutions 
lOx Milk Buffer 	12.lg Tris, 57.7g NaCl, dissolved in 800m1 H20 and pH 
adjusted to 8.1. 5m1 Tween-20 was added and the volume 
made up to 1 litre. 
Developer 	60mg 4-chloro-1-napthol dissolved in 20m1 methanol. lOOml 
1X milk buffer and 100 jil hydrogen peroxide was added prior 
to use. 
2.4.11 ECL Solutions 
PBS-T 	 PBS with 0.1% (v/v) Tween-20 
1.2501*I Luminol 	0.44g Luminol dissolved in lOml DMSO, stored at 4'C in the 
dark 
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2.90mM p-Coumaric acid 
0.15g p-Coumaric acid dissolved in lOS DM50, stored at 
4°C in the dark 
Solution A 	irni Luminol stock, 0.44m1 p-Coumaric acid stock, lOml Tris- 
HC1 (pH 8.5) and made up to lOOmI with water. Stored at 
4°C in the dark 
Solution B 	lOml Tris-HCI (pH 8.5), 61ji.1 30% H 202, and made up to 
lOOmI with water. Stored at 4°C in the dark, and made 
weekly. 
ECL detection solution 
Solutions A and B mixed 1:1, just before use 
2.4.12 in situ Hybridisation Solutions 
pp (fix) 	 2g paraformaldehyde was dissolved carefully in 40m1 H 20 (in 
65 ° C water bath) by adding 301.11 IOM NaOH and shaking 
occasionally. At high pH the paraformaldehyde dissolves 
easily. Sml 0.5M PIPES pH7.0, 100111 0.5M EGTA pH8 and 
lOOpi 1M Mg504 was then added and the pH checked as 
—6.8. The volume was adjusted to 50m1 with water and stored 
at 4°C for up to 24 hours. 
Hybrix 	 50% formamide, 5x SSC, 100gIml sonicated, heat denatured 
salmon sperm DNA (5sDNA), 50gIml heparin, 0.1% 
Tween-20. 
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NMTT 	 100mM NaCl, 50mM MgC12, 100mM Tris (pH 9.5), 0.1% 
Tween-20, 1mM Levamisol (fresh). 
NBT 	 75mg/mi NBT in 70% dimethyifonnamide 
X-phosphate 	50mg/mi X-phosphate in 100% dimethylformamide 
2.5 METHODS 
The spectrophotometer used was a Perkin-Elmer, Lambda 15, UV/VIS 
Spectrophotometer. 
2.5.1 Microbiological Techniques 
2.5.1.1 Growth of E.coli Bacterial Cultures 
Liquid cultures of E. coli were gown in LB, containing antibiotic if necessary, at 
37*C with shaking. Cultures geater than lOmIs were gown in conical flasks with a 
capacity of 5-1 OX that of the culture volume to allow proper aeration during gowth. 
Cultures were also grown on the surface of Luria agar plates at 37 C C. 
2.5.1.2 Storage of E. coli Bacterial Cultures 
For short term storage (4-6 weeks) bacteria were streaked onto Luria agar plates, and 
stored at (C. For longer ten" storage, 500pl of a fresh culture, gown overnight in 
LB, was mixed with 5001.11 glycerol, and frozen at -70C. Cells were recovered by 
scraping the surface of the frozen culture with a sterile inoculating loop and streaking 
onto a Luria agar plate. 
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2.5.1.3 Preparation and Transformation of Competent Cells 
The E. coli strains XL1-Blue and BL2I (DE3) were made competent using either of 
the following methods. 
2.5.1.3.1 DMSO method 
LB media was inoculated with an overnight culture of bacteria, to give a 1:100 
dilution of the culture. The bacteria were then gown at 37°C, with shaking 
(225rpm), to the early exponential phase (A600 0.3-0.4). The cells were pelleted by 
centrifugation at 1000xg for 10 minutes at 4°C and the pellet resuspended in ice-cold 
TSS in one-tenth of the original culture volume. The cells were pipetted into 200jil 
aliquots, quick-frozen in a dry ice/isopropanol bath and stored at -70°C until they 
were needed. 
2.5.1.3.2 RbCI method 
Srnl LB medium was inoculated with a single colony from an LB plate and incubated 
overnight at 37°C with shaking (approx. 225rpm). On the following day, 250ml LB 
medium, containing 20mM MgSO4, was inoculated with 2.5ml of the overnight 
culture and gown in a 1 litre flask until the A600 reached 0.4-0.6. The cells were 
centrifuged at 4,500xg for 5 minutes at 4°C. The cell pellets were gently resuspended 
in lOOml of ice-cold TFB1, and all subsequent steps were performed on ice. The 
resuspended cells were incubated on ice for 5 minutes, then pelleted by centrifugation 
at 4,500xg for 5 minutes at 4°C. The cells were gently resuspended in lOml of ice-
cold TBF2 and incubated on ice for 15-60 minutes. Then the cells were divided in to 
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200R1 aliquots, quick-frozen in a dry ice/isopropanol bath and stored at -70°C until 
they were needed. 
2.5.1.3.3 Transformation of Competent Cells 
Aliquots of competent cells were thawed on ice and used immediately upon thawing. 
Transformation was carried out by mixing approximately 50ng DNA with lOOjil cells 
followed by incubation on ice for 30 minutes. For the RbC1 method, the cells were 
heat shocked at 42°C for 1 minute in a water bath. The DMSO method does not 
require heat shock. LB media (900tl) was then added and the cells incubated at 37°C 
for 1 hour with shaking, to allow expression of antibiotic resistance. The culture was 
then spread onto antibiotic plates to select for transformants. 
Where appropriate, 30R1  of 2% (w/v in dimethylfonnamide) X-Gal and 201.ii of 
100mM IPTG were also spread over the surface of the plate to enable blue-white 
colour selection of colonies containing recombinant plasmids. 
2.5.1.4 Small Scale Preparation of Plasmid DNA 
2.5.1.4.1 Plasmid DNA minipreps 
A modification of the method described by Ish-Horowicz and Burke (198 1) was used 
to prepare amounts of plasmid DNA up to lO.tg. Bacteria were gown overnight at 
37C in 5m1 LB supplemented with ampicillin. to a final concentration of lOOjigIml. 
1 .5m1 of the culture was transferred to a microfüge tube, and the cells pelleted by 
centrifugation for 5 minutes. The pellet was resuspended in 2001.11 of solution P1, and 
the cells lysed by addition of 200j.11 of solution P2 with 5 minutes incubation at room 
temperature. 200111 of cold solution P3 was added, with gentle mixing, and the tube 
incubated on ice for 15 minutes. Precipitated chromosomal DNA, SDS and protein 
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were sedirnented by centrifugation for 30 minutes at 4's, and the supernatant, 
containing the plasmid DNA, removed to a fresh tube. Plasmid DNA was 
precipitated by the addition of imi isopropanol. Following 15 minutes 
centrifugation, the nucleic acid pellet was washed with 70% (v/v) ethanol, air dried, 
resuspended in 20R1  H20 and stored at -20 0C. 
2.5.1.4.2 Promega minipreps 
The Proinega WizardTM  Plus Minipreps DNA Purification System was used to 
prepare DNA for automated sequencing. Procedures detailed in the manufacturer's 
handbook were followed, an initial culture volume of 5ml was used and 50j.tl H 20 
was used to elute the final DNA sample. 
2.5.1.5 Large Scale Preparation of Plasmid DNA 
For general stocks of plasmid DNA, the Hybaid kit was used. The CsC1 2 method and 
Qiagen kit were used to prepare plasmid DNA for microinjection of Drosophila 
embryos. 
2.5.1.5.1 CsC12 Method 
A bacterial colony, containing the plasmid of interest, was picked using a sterile 
toothpick and inoculated into 2m1 LB media with lOOj.tglml ampicillin and incubated 
at 37°C for 5 hours with shaking. The 2m1 culture was transferred into 300m1 LB 
media with 100tgIml ampicillin and incubated at 37°C overnight with shaking. The 
cells were pelleted by centrifugation at 6,000 rpm for 10 minutes, and the pellet 
resuspended in 4m1 TGE buffer by vortexing. 8m1 0.2N NaOHI1% SDS (made fresh) 
was added and incubated on ice for 15 minutes, then 6ml 3M potassium acetate pH 
5.0 was added and incubated on ice for 15 minutes. The sample was then centrifuged 
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at 13,000 rpm for 10 minutes and the supernatant transferred to a new tube. Plasmid 
DNA was precipitated by the addition of lOml isopropanol, incubation at room 
temperature for 10 minutes and then centrifuging at 13,000 rpm for 10 minutes. The 
DNA pellet was dissolved in 8.6ml TE buffer at 4°C overnight. 
To perform the CsCl 2 purification, 8.6g CsCl 2 and 520111 ethidium bromide (lomglml 
stock) was added at room temperature and centrifuged at 5,000 rpm to remove any 
protein-EtBr complexes that had formed. The supernatant was transferred to a Ti50 
ultracentrifuge tube, and all tubes were balanced carefully and sealed before 
centrifuging at 45,000 rpm for at least 36 hours in an ultracentrifuge. Following 
centrifugation, the band of DNA in the tube was visualised with UV light and 
removed using a needle and syringe (after puncturing the top of the tube with another 
needle, to give air exchange). The DNA was extracted with water saturated butanol to 
remove the ethidium bromide, an equal volume of butanol was added, mixed with the 
DNA and then removed. This process was repeated until all of the ethidium bromide 
had been removed and the DNA solution was colourless. The volume of the sample 
was made up to 5m1 with TE buffer, and the DNA precipitated by the addition of 
1 3m1 100% ethanol. If the sample volume was larger than 5m1, sodium acetate was 
added with the ethanol to raise the salt concentration. The DNA was pelleted by 
centrifugation at 5,000rpm for 5 minutes, the DNA pellet was washed with 70% 
ethanol and dried at 37°C for 5 minutes. The DNA was then dissolved in 0.5ml TE 
buffer. 
To prepare the DNA for microinjection, the DNA was extracted twice with phenol-
chloroform and once with chloroform only, then precipitated with 50111 sodium 
acetate and 350111 isopropanol and centrifuged at 13,000 rpm for 10 minutes. The 
DNA pellet was washed with 70% ethanol and dried at 37°C for 5 minutes. Finally 
the DNA was resuspended in 250111 buffer. 
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2.5.1.5.2 QIAGEN QIAIiIter TM Plasmid Midi Kit 
The QIAGEN QIAfilter TM Plasmid Midi Kit was found to give an acceptable 
transformation frequency when used for P-element mediated transformation, and had 
the advantage of taking very little time to perform compared with the standard CsCl2 
method. Phenol-chloroform extraction, prior to use in microinjection procedures, was 
also found to be unnecessary. Procedures detailed in the manufacturer's handbook 
were followed with the exception of the initial culture volume used; instead of the 
recommended 25ml culture, a volume of 15ml was used to ensure that the column 
was not overloaded and DNA purity would be optimal. 
2.5.1.5.3 HYBAID RECOVERYTM  Plasmid Midi Prep Kit 
The HYBAID RECOVERYTM  Plasmid Midi Prep Kit was used for general plasmid 
preparations. The protocol detailed in the manufacturer's handbook was followed 
and usually the DNA in the final step was eluted with 250pJ H20 and stored at 
-20'C. 
2.5.2 Manipulation and Detection of Nucleic Acids 
2.5.2.1 Estimation of Plasmid DNA Yields 
DNA samples were diluted in lml 1120 and the absorbance(A) at 260 and 280nm 
was measured in a spectrophotometer. Double stranded DNA of concentration 
50tgIml has an A260 = 1.0. The ratio A260/A250 gives an estimate of nucleic acid 
purity. For DNA, a value of around 1.8 indicates that the preparation is not 
significantly contaminated with protein or phenol. Estimates of DNA concentrations 
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were also obtained by visual comparison of DNA samples to a known quantity of 
2LDNA on an agarose gel stained with ethidium bromide. 
2.5.2.2 Phenol-Chloroform Extraction 
Phenol-chloroform extraction is used to remove protein from DNA solutions. Phenol 
was equilibrated with Tris-HC1 pH 8 as described by Sambrook et al. (1989) then 
mixed in a ratio 25:24:1, phenol : chloroform : iso-amyl alcohol respectively, and 
stored at (c. 
DNA was extracted by adding an equal volume of phenol-chloroform and mixed by 
vortexing, or by gentle inversions if the DNA fragments were large. The two phases 
were separated by centrifugation at 12,000 xg for 5 minutes, and the upper, aqueous 
phase was removed to a fresh tube. If necessary, the extraction was repeated, and to 
increase recovery, the organic phase could be back-extracted with a small volume of 
water or TE buffer. A final extraction with an equal volume of chloroform was 
performed to ensure complete removal of phenol. 
2.5.2.3 Precipitation of DNA 
DNA was precipitated by adding 0.1 volume of 3M sodium acetate, pH 5.2, and 2 
volumes of 100% ethanol. The sample was then incubated at -20C for at least 30 
minutes, and the DNA pelleted by centrifugation at 12,000 xg for 15 minutes, or 30 
minutes for small fragments. The supernatant was carefully removed and the pellet 
washed with 200R1  70% ethanol, to remove any residual salts, and centrifuged at 
12,00 xg for 5 minutes. The ethanol was removed and the DNA pellet air dried and 
dissolved in an appropriate solution and volume for further manipulation. 
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2.5.2.4 Restriction Endonuclease Digestion of DNA 
DNA was digested with 5 units of the required endonuclease per 1g of DNA, using 
buffer and temperature conditions recommended by the manufacturer. For double 
digests involving enzymes with different buffer requirements, reactions were either 
carried out under intermediate buffer conditions, or DNA was digested in two 
sequential steps separated by a DNA purification procedure. Reactions were halted 
by addition of lOX DNA loading buffer or by heating at 65C for 10 minutes. 
2.5.2.5 Agarose Gel Electrophoresis of DNA 
DNA fragments were separated on 0.8-2% (wlv) electrophoresis grade agarose gels 
containing 0.5igIml ethidium bromide and 1X TAB. DNA samples were mixed with 
1 / 10 volume of lOX DNA loading buffer prior to loading. Gel tanks were supplied by 
Bioscience Services, NBL and Bio-Rad. Mini-gels were run at 50-1Oy for 1-2 hours 
and midi-gels were run at 100-150V for 1-2 hours. After electrophoresis, DNA was 
visualised by ultra-violet illumination. 
2.5.2.6 Molecular Weight Markers 
The sizes of DNA restriction fragments were determined by comparing the distance 
migrated in the gel to that of known molecular weight markers, a 1 kilobase ladder 
(1 kb ladder from Gibco BRL) was used. 
2.5.2.7 Recovery of DNA from Agarose Gels 
Two methods were used to purify DNA fragments from agarose gels: the QIAGEN 
QlAquick and QIAEX II kits. The protocols detailed in the manufacturer's 
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handbooks were followed for each procedure. Usually DNA was eluted in 20jxl H 20 
with the QIAEX II kit and 30.tl H 20 with the QlAquick kit. 
2.5.2.8 Ligation of DNA Molecules 
2.5.2.8.1 Dephosphorylation 
Calf intestinal alkaline phosphatase (ClAP) was used to dephosphorylate linearised 
plasmid vectors, prior to insert ligation, to prevent vector recircularisation and 
increase the frequency of recombinant plasmids produced. Approximately lig of 
DNA, in 90jfl H 20, was mixed with 10L'1  of lox ClAP buffer and 1 unit of ClAP. 
The reaction mix was incubated for 30 minutes at 37 CC, following which the DNA 
was purified to remove all traces of the enzyme. 
2.5.2.8.2 Creation of blunt ends 
Klenow Polymerase was used to convert a 5' overhang to a blunt end terminus. 
Approximately lg of DNA was incubated in lx Klenow buffer containing 40iM 
of each dNTP and 1 unit of Klenow Polymerase, in a total reaction volume of 50j.il. 
The reaction mix was incubated for 30 minutes at room temperature, following which 
the DNA was purified to remove all traces of the enzyme. 
2.5.2.8.3 Ligation 
After the vector and insert DNA had been prepared for ligation, the concentration of 
each was estimated by agarose gel electrophoresis along with DNA standards of 
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known concentration. The vector and insert DNA ratio used was 1:3 molar ratio of 
vector: insert, this was calculated according to the following equation: 
ng of vector x kb size of insert 	x 	molar ratio of insert 	= ng of insert 
kb size of vector 	 vector 
Ligation reactions were set up with lOOng vector DNA and the appropriate amount 
of insert DNA in a total volume of 10R1  also containing ijil lOx Ligase Buffer and In 
T4 DNA Ligase (Weiss units). The reactions were incubated at 18°C overnight, then 
used to transform competent cells of a suitable bacterial host strain. 
2.5.2.9 Polymerase Chain Reaction 
Ready-To-GoTM  PCR beads (Pharmacia Biotech) were used for PCR reactions. When 
brought to a final volume of 25jil, each reaction contained -1.5 units of Taq, 10mM 
Tris-HC1, 50mM KC1, 1.5mM MgCl2, 200!IM  of each dNTP and stabilisers, 
including BSA. Approximately lOOng of DNA was used per reaction, along with ing 
of each primer and sterile distilled H 20 was added to a final volume of 25jil. PCR 
reactions were overlaid with a drop of mineral oil if the thermal cycler did not have a 
heated lid. Cycle conditions varied for different primer pairs, but denaturation was 
generally carried out at 95 C C for 1 minute, followed by 1 minute at an appropriate 
annealing temperature, and synthesis at 72 C C for 1 to 2 minutes. 30-35 cycles were 
carried out for most PCR reactions. All experiments were carried out using an 
Omnigene thermal cycler (Hybaid Ltd.). 
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2.5.2.10 DNA Sequencing 
Two methods were used for DNA sequencing; initially manual sequencing was 
performed, until automated sequencing facilities became available. All sequencing was 
carried out using the cloning vector pBluescript (Stratagene) and the P-element 
transformation vector pERT. The T3 and T7 primers were used for pBluescript 
sequencing, and the primers Adh and White were used for pERT sequencing. 
2.5.2.10.1 Manual Sequencing 
The dideoxy chain termination method of Sanger et at (1977) was used in the form of 
a SequenaseTM  Version 2.0 kit (United States Biochemical). Double stranded DNA 
was sequenced according to the kit manual, labelling the sequenced DNA with ct 35 S 
dATP. The sequencing reactions were run on a 6% polyacrylamide gel in TBE buffer 
containing 7M urea, with TBE as electrophoresis buffer. Gels were electrophoresed 
at a constant power setting of 40W for 40cm gel size for the required length of time. 
The gels were transferred to filter paper and dried under vacuum for 1-2 hours at 
80°C. The dried gels were exposed to X-ray film at room temperature for 1-3 days 
depending on the amount of radioactive signal present. 
2.5.2.10.2 Automated Sequencing 
DNA sequencing was performed using an ABI PRISM dye terminator cycle 
sequencing reaction ready kit (Perkin-Elmer Corporation), on an Omnigene thermal 
cycler (Hybaid Ltd.) and extension products separated on an ABI PRISM 377 DNA 
sequencer (Perkin-Elmer Corporation). 
Approximately 0.4jig of double stranded DNA template was mixed with 3.2pmoles 
of an appropriate oligonucleotide primer and 81i1  of terminator ready reaction mix in a 
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final volume of 20jsl. The mixture was overlaid with a drop of mineral oil, and 
subjected to thermal cycling as follows: 96°C for 30 seconds, 50°C for 15 seconds, 
60°C for 4 minutes, repeated for 25 cycles. 
Extension products were purified away from unincorporated terminators by addition 
of 2.0jfl 3M sodium acetate pH 4.8, 50jil absolute ethanol, and incubation on ice for 
10 minutes followed by 15 minutes centrifugation. The resulting pellet was washed 
with 70% (v/v) ethanol, air dried, and stored dry at 4°C prior to electrophoresis. 
2.5.2.11 Sequence analysis 
Sequence analysis was carried out on a UNIX mainframe computer using the 
Genetics Computer Group (GCG) package of programs, version 9 (Genetics 
Computer Group 1996). Sequence editing was performed using the Seqed program, 
manual sequences were input by hand while sequences generated by the automated 
sequencer were edited with GeneJockeyll (Biosoft) before transfer. Nucleotide 
sequences were analysed using the programs Gap and Bestfit, while nucleotide and 
protein database searches were carried out using Fasta and Blast functions. 
2.5.3 Manipulations of Drosophila Stocks 
2.5.3.1 Establishment of Transgenic Lines by P-Element Transformation 
P-element mediated germ line transformation (Rubin and Spradling, 1982) of wr 
Drosophila embryos was performed with DNA prepared by either the CsC1 2 method 
or the QIAGEN QIAfilter method. The transformation construct to be tested was 
mixed with the helper plasmid pA2-3 at a ratio of 4:1, then ethanol precipitated and 
resuspended in injection buffer (5mM KC1, 0. 1mM NaPO 4 pH6.8) to give a final 
concentration of 400jigIml of transformation construct and lOOjig/mI of helper 
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plasmid. The DNA was centrifuged for 1 minute in a microffige to spin down any 
debris, taken up into a microloader (Eppendorf) and then loaded into an injection 
needle (Eppendorf). The needle was then mounted in the micromanipulator and 
stored under Kel-F oil when not in use to prevent drying. 
Embryos were collected every 45-60 minutes from 4-10 day old wr flies kept in a 
population cage containing a detachable apple juice plate to allow easy removal of 
newly laid embryos. Embryos were dechorionated manually by gently rolling across 
double sided adhesive tape (Scotch brand 3M No.666) mounted on a microscope 
slide. The dechorionated embryos were lined up on the edge of a coverslip, on a 
narrow strip of tape, with their posterior ends positioned just over the edge of the 
coverslip. The embryos were desiccated by leaving the microscope slide under the 
light of the microscope for 5-7 minutes (depending on the humidity and temperature 
of the room, and how long it took to dechorionate them). The embryos were then 
covered with Kel-F halocarbon oil and mounted on the stage of the micromanipulator. 
DNA was carefully injected into the posterior pole of preblastoderm embryos prior 
to pole cell formation, or stage 1 and 2 embryos (Bownes, 1975). Embryos at later 
stages of development were destroyed by tearing the vitelline membrane or injecting a 
fatally large quantity of DNA. Injected embryos were incubated on tomato juice 
plates with a small spot of yeast paste at 25°C for 24-36 hours, and larvae collected 
as they emerged. Larvae were placed in vials of fly food and incubated at 25°C. When 
adult flies eclosed, they were individually mated with 2-3 wr virgins and the progeny 
examined for a red eye phenotype. Individual transformants were crossed with 2-3 
wr virgins and homozygous lines established by sibling matings with the progeny 
from these crosses. Stably transformed lines were used for histochemical staining. 
2.5.3.2 Histochemical Staining of Transformed Drosophila 
Flies were dissected in Ringer's Solution and stained for -galactosidase activity 
overnight at 4°C in lOOj.tl of X-gal Staining Buffer. f3-galactosidase activity 
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represents lacZ reporter gene expression, indicated by blue colouration appearing 
over several hours. 
2.5.3.3 Extraction of Haemolymph Samples from Drosophila 
Glass needles were pulled from 25il Drummond glass microcapillaries using a 
vertical pipette puller (Model 700C, David Kopf Instruments, Tujunga, California). 
Flies were lightly etherised and attached by their wings to a microscope slide using 
double sided adhesive tape. The haemolymph was collected with a glass needle 
through the throat of each fly and pooled in Ringer's solution incubated on ice, then 
stored at -20°C, until ready for SDS-PAGE analysis (section 2.5.4.7). 
2.5.4 Protein Expression and Purification 
The methods for protein expression and purification have been adapted from Erdman 
and Burtis (1993). 
2.5.4.1 Expression 
A single colony of K coli BL21 (DE3) cells containing a recombinant pGEX plasmid 
was used to inoculate SOml LB media with lOoiglml carbenicillin. This culture was 
incubated overnight at 37°C with shaking, and subsequently used to inoculate 450ml 
LB media containing lOOjig/mI carbenicillin, in a 2 litre flask. The culture was gown 
for 1 hour at 37°C with shaking, and was then induced with 0. 1mM isopropyl-0-D-
thio-galactopyranoside (IPTG) for 4 hours, after which the cells were harvested by 
centriftigation at 5000 rpm for 5 minutes. A control culture of E. coli BL21 (DE3) 
cells without a pGEX plasmid was produced at the same time. 
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2.5.4.2 Preparation of glutathione-agarose 
Approximately ig glutathione-agarose beads were put into a lSml tube and washed 
3X with lOmi PBS, using 1 minute spins at 1000 rpm in a centrifuge to collect the 
beads at the bottom of the tube. Then the glutathione-agarose beads were 
resuspended in an equal volume of PBS and left to hydrate and swell overnight at 
4°C. Then the beads were equilibrated in Z-100 buffer and finally resuspended in an 
equal volume of Z-lOO, to give 50% glutathione-agarose beads. 
2.5.4.3 Purification 
Harvested cells were resuspended in 20ml cold Z-100 buffer containing lysozyme 
and incubated on ice for 15 minutes. The cell suspension was sonicated on ice for 2 
minutes and the lysate centrifuged at 10000 rpm for 10 minutes at 4°C. The 
supernatant was removed to a lSml tube and imI 50% glutathione-agarose beads 
were added and incubated at 4°C with gentle shaking for 30 minutes, to bind the 
GST-fusion protein to the beads. After washing twice with lOml cold Z-100 
proteins were eluted from the beads twice in 2ml cold Z-100, 10mM reduced 
glutathione, 5mM NaOH, and stored at 4°C until dialysed. 
The control extract supernatant was stored at 4°C after lysate centrifugation, without 
undergoing GST purification. 
200j.tl samples were taken at each stage to allow the purification stages to be 
monitored. 
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2.5.4.4 Dialysis 
2.5.4.4.1 Preparation of Dialysis Tubing 
Dialysis tubing was prepared as described by Sambrook et al. (1989), the tubing was 
cut into pieces of convenient length, approximately 10-20cm. The pieces of dialysis 
tubing were boiled for 10 minutes in a large volume of 2% (wlv) sodium bicarbonate 
iniM EDTA (pH 8.0), and then rinsed thoroughly in distilled water. The tubing was 
boiled for a further 10 minutes in 1mM EDTA (pH8.0) and then allowed to cool and 
stored at 4°C, with the tubing submerged in the solution. Before use, the tubing was 
washed inside and out, and boiled briefly for 5 minutes in distilled water. 
2.5.4.4.2 Dialysis 
Purified GST-fusion protein was pipetted into a piece of dialysis tubing and sealed 
with plastic clips, leaving room for possible expansion of the sample during dialysis. 
The tubing was suspended over a 2 litre beaker containing 1.8 litres of Z-50 or PBS 
buffer at 4°C, using a glass rod and elastic band, so that the entire piece of tubing was 
submerged. The protein sample was dialysed overnight at 4°C with gentle stirring. 
This was repeated the next day with fresh Z-50 or PBS buffer for at least 6 hours, 
then the sample was removed from the tubing, and stored at -20°C. 
2.5.4.5 Estimation of Protein Concentration 
Protein concentrations were estimated using the Bradford method (Bradford, 1976). 
The Bradford method depends on quantitating the binding of a dye, Coomassie 
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Brilliant Blue, to an unknown protein and comparing this binding to that of different 
amounts of a standard protein, usually bovine serum albumin (BSA) 
Duplicate amounts of 0.5mg/mI BSA (5, 10, 15 and 20il) were measured into 
microfuge tubes and made up to lOOjfl with 0.15M NaCl. Two blank tubes contained 
lOOj.d 0.1 SM NaCl. lml Coomassie Brilliant Blue solution was added to each tube 
and vortexed, then allowed to stand 2 minutes at room temperature. The A 595 was 
measured using a 1cm pathlength cuvette and a standard curve constructed by 
plotting absorbance at 595nm versus protein concentration. The standard curve can 
then be used to determine the protein concentration of the unknown sample, by 
determining the unknown absorbance. This method can be used to quantify ito 10g 
of protein. 
2.5.4.6 Concentration of Protein Samples 
The purified GST-fusion protein samples were often not concentrated enough for use 
in assays and for antibody production. The samples were concentrated using an 
liltrafree-4 centrifugal filter unit (Millipore), the sample was pipetted into the unit 
and then placed in a lSml disposable centrifuge tube. This was centrifuged at 5,000 
rpm at 4°C until the sample occupied the desired volume, then the sample was 
recovered from the unit with a pipette and stored at -20 ° C. 
2.5.4.7 SDS-Polyacrylamide Gel Electrophoresis of Proteins (Laemmli, 1970) 
Protein gel plates were washed and assembled according to the manufacturer's 
instructions. The separation mix was poured between the plates, overlaid with a 
small volume of H 20 and allowed to set for approximately 30 minutes. The H 20 was 
poured off and stacking gel mix was poured between the plates before the comb was 
inserted in the top of the gel. When set, the gel was fixed into the gel tank (supplied 
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by ATTO) and lx running buffer was poured into the reservoirs in the tank. Protein 
samples and Drosophila tissues used for electrophoresis were mixed with an equal 
volume of 2X sample buffer, these samples were boiled for 10 minutes and briefly 
centrifuged before loading onto the gel. 1 Suil pre-stained markers (low range, supplied 
by Bio-Rad) were boiled for 3 minutes prior to loading on the gel. Electrophoresis 
was generally carried out overnight at 35-50V. 
After electrophoresis gels were fixed in 12% (wlv) TCA for 1 hour at room 
temperature, and stained using the 155 Pro-Blue Staining System. Initially the gel was 
incubated in lOOmi pretreatment solution (Reagent A diluted 1:5 with deionised 
water) for 1 hour at room temperature. The gel was then incubated in stain solution 
(1 6ml Reagent A, 64m1 H 20, 1 .6m1 Reagent B and 20m1 methanol) for 3-16 hours at 
room temperature. The gel was destained with 25% methanol at room temperature, 
with shaking, to obtain a clear background. 
2.5.5 Antibody Production and Immunostaining 
2.5.5.1 Protein Preparation for Injection 
Protein was expressed and purified as described in section 2.5.4. The initial purified 
protein sample was in Z-50 buffer, which is not suitable for injection into animals. 
The protein sample was dialysed into PBS, and the resulting concentration of the 
sample was measured. The protein sample was concentrated using an Ultrafree-4 
centrifugal filter unit (Millipore) until the protein concentration was approximately 
1g/Il. A sample of the protein was checked by SDS-PAGE prior to injection into 
mice. The research adjuvant TiterMax ®Gold was used to provoke an immune 
response to the antigen in mice. A mouse can be injected with a total volume of 
100p1, and the antigen was mixed with adjuvant at a 50:50 ratio, the two components 
were mixed by vortexing until an emulsion formed. 
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2.5.5.2 Antibody Production in Mice 
Five MF1 mice were anaesthetised with Halothane and each bled from the eye (10 
drops of blood) to give a sample of pre-immune serum. The mice were then injected 
with lOQil of a stable emulsion of antigen-TiterMax ®Gold, which contained 50pJ of 
antigen (1jig/fl protein) and 50R1  TiterMax®Gold. The injections were given 
subcutaneously at the base of the tail. Primary bleeds were taken after 4 weeks by 
bleeding from the eye and a boost injection of antigen (50p1 of 1g/pJ protein) in PBS 
was given after 6 weeks. Secondary bleeds were taken after a further 3 weeks and the 
mice were bled out after another 16 weeks. All the mouse handling and serum 
preparation was performed by Kay Samuel (ICAPB, Edinburgh). 
2.5.5.3 Western Blotting 
Proteins were transferred from gels onto Hybond C-super membrane by 
electroblotting using a Trans-Blot SD semi-dry transfer cell (Bio-Rad). The gel was 
equilibrated in transfer buffer for 10 minutes. Three pieces of blotting paper, soaked 
in transfer buffer, were placed on the bottom electrode plate of the unit, one at a time 
ensuring no air bubbles remained trapped between layers. On top of this was laid the 
membrane, the gel, and three further pieces of blotting paper soaked in transfer 
buffer, again checking for air bubbles. The other electrode plate was positioned on 
top to complete the circuit, and proteins were transferred at 15V for 3 hours. In order 
to confirm that complete transfer had occurred, the membrane was stained in Ponceau 
S solution for 2 minutes and the transfer checked, then destained with 1120. 
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2.5.5.4 Immunostaining 
Two different methods were used for immunodetection depending upon the 
sensitivity required; the ECL method gives much geater sensitivity than the HRP 
detection method. 
2.5.5.4.1 HRP Method for Immunodetection 
Following Ponceau S destaining the Western filter was incubated for 1 hour at 37°C 
in 1 5m1 3% milk (fat free powdered milk dissolved in lx milk buffer), in a plastic 
bag, with shaking. The milk solution acts as a blocking reagent to minimise non-
specific binding of antibodies during subsequent stages of immunodetection. The 
filter was then placed in a fresh bag and incubated in 15m1 3% milk, containing 1° 
antibody, for 2 hours at 37°C with shaking. The 1° antibody was removed and stored 
at 4°C for future use. The filter was washed 5x 5 minutes in lx milk buffer at room 
temperature with shaking. The filter was then placed in a fresh bag and incubated in 
15m1 3% milk, containing 2° antibody (horseradish peroxidase, HRP, conjugated), for 
1 hour at 37°C with shaking. The 2° antibody was discarded and the filter was 
washed 5x 5 minutes in lx milk buffer at room temperature with shaking. The filter 
was placed in developing solution and incubated at room temperature in the dark, 
with shaking. When the staining had reached the desired intensity on the filter, the 
filter was washed with H20, dried, and stored in the dark to prevent the stain from 
fading. It is not possible to reprobe filters with this detection method. 
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2.5.5.4.2 ECL Method for Immunodeteetion 
Following Ponceau S destaining the Western filter was incubated overnight at 4°C (or 
1 hour at room temperature with shaking) in 5% blocking reagent (fat free powdered 
milk) in PBS-T. The filter was rinsed twice in PBS-T, washed once for 15 minutes 
and twice for 5 minutes with PBS-i' at room temperature, with shaking. The filter 
was placed in a plastic bag and incubated with 1° antibody, diluted in PBS-T, for 1 
hour at room temperature. The filter was rinsed twice in PBS-T, washed once for 15 
minutes and twice for 5 minutes with PBS-T at room temperature, with shaking. The 
filter was then placed in a fresh bag and incubated with 2° antibody (HRP 
conjugated), for 1 hour at room temperature with shaking. The 2° antibody was 
discarded and the filter was rinsed twice in PBS-T, washed once for 15 minutes and 
four times for 5 minutes with PBS-i' at room temperature, with shaking. For the 
antibody detection solution, equal volumes of solutions 1 and 2 were mixed, in 
sufficient volumes to cover the filter. The filter was drained of PBS-T and placed 
protein side facing up on a piece of SaranWrap, the detection solution was added to 
cover the entire surface of the filter and incubated for 1 minute at room temperature 
without agitation. Excess detection solution was drained from the filter, and the filter 
was wrapped in SaranWrap, any air bubbles were smoothed out. The filter was 
placed protein side up in a film cassette and exposed to film (in the dark) for 15 
seconds and the film developed. Depending upon the intensity of the signal the filter 
was exposed to film until the desired exposure was achieved. It is possible to reprobe 
filters several times with this detection method. 
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2.5.6 Gel Retardation Assays 
2.5.6.1 Radioactive End-labelling of Probe 
200ng of digested, gel-purified DNA fragment was incubated in a total volume of 
301.11 with 3j.0 lOx Klenow Buffer (supplied with Klenow enzyme), 3111  20mM 
nucleotide solution (dATP, dGTP and dTTP), 2pl (201.tCi) a- 32P[dCTP] and liii  of 
E. coli DNA polymerase I Klenow fragment (SuIj.tl). The labelling reaction was 
allowed to proceed for 30 minutes at room temperature, after which 51i1 5mM dCTP 
was added and the reaction incubated for a further 30 minutes at room temperature. 
The reaction volume was made up to 50111 with TE buffer, and the radiolabelled 
fragments separated from unincorporated nucleotides by purification through a 
Sephadex G-50 NICK TM  Column (Pharmacia Biotech). The column was rinsed and 
equilibrated with 3m1 TE buffer, and the labelled DNA was added to the column. 
400111 TE buffer was then added and passed through the column, and a further 400111 
TE buffer was used to elute the labelled DNA from the column. The 400111 eluted 
probe was ethanol precipitated overnight at -20°C and resuspended in 20111 TE 
buffer to give a probe concentration of approximately 10ngIl and 10-30cps/j.tl 
radioactivity. 
2.5.6.2 DNA-binding Reactions 
GST-DSX binding domain protein (approximately 2g protein) was incubated in a 
total volume of 20111 with 4111  5x Z-50 buffer, lOng 32P end-labelled DNA probe and 
varying amounts of specific or non-specific (poly[dIdC]) competitor DNA. The 
binding reactions were incubated at room temperature for 30 minutes, then 5111  5x gel 
shift loading buffer was added and the samples immediately loaded onto 
nondenaturing polyacrylamide gels for electrophoresis. 
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2.5.6.3 Nondenaturing Polyacrylamide Gel Electrophoresis of Protein-DNA 
Binding Reactions 
1mm, 4% nondenaturing high ionic strength polyacrylamide gels were pre-run, in high 
ionic strength electrophoresis buffer, for 1-2 hours at 150V. The entire volume of the 
binding reactions were loaded onto the gels and run at 150V. The length of 
electrophoresis depended upon the size of the probe, -200bp probes were run for 2 
hours and '-400bp probes for 3 hours. Following electrophoresis the gels were 
transferred onto dampened blotting paper and dried under vacuum at 80°C for 1-2 
hours. The dried gels were either autoradiographed at -20°C or exposed in a 
phosphorimager cassette overnight, or longer if required. 
2.5.6.4 Autoradiography 
Radioactive signals from dried DNA sequencing gels and dried protein gels were 
detected using blue sensitive X-ray flhn (Genetic Research Instrumentation) and 
cassettes with intensifying screens at -70°C for 32P, and room temperature for 35 S. 
The same X-ray film and cassettes were used for ECL immunodetection. Films were 
developed in an X-ograph CompactX2 automatic film processor. 
2.5.6.5 Phosphorimagery 
Phosphorimagery was performed using a storage phosphor screen (Molecular 
Dynamics). After exposure of the screen, signals were visualised through a Molecular 
Dynamics phosphorimager, and analysed with ImageQuant software. 
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2.5.7 In situ Hybridisation to Drosophila ovaries 
2.5.7.1 Preparation of digoxygenin labelled DNA 
2.5.7.1.1 DNA probes 
lSOng DNA, dissolved in 19111 water, was denatured by boiling in a waterbath for 5 
minutes and snap frozen in a dry-ice/ethanol bath. While still frozen, 2.5111 
hexanucleotides and 2.5111 DIG DNA labelling mix (Boehringer Mannheim) was 
added. Once thawed, 1 111  (1 unit) Klenow polymerase was added and the reaction 
incubated at 37°C overnight. The reaction was stopped by adding 1111  0.5M EDTA, 
and the labelled DNA was precipitated by adding 2111  4M LiCl and 60111  prechilled 
100% ethanol, incubated at -70°C for at least 30 minutes and centrifuging at 17,000 
rpm for 15 minutes at 4°C. The DNA pellet was washed with 70% ethanol, air dried 
and resuspended in 150111 hybrix. Immediately prior to use, the labelled DNA probe 
was denatured by boiling for 5 minutes and snap freezing in a dry-ice/ethanol bath. 
2.5.7.1.2 PCR probes 
DNA probes labelled with the PCR DIG labelling mix (Boehringer Mannheim) can 
give increased sensitivity compared to the standard DNA probes. This is particularly 
useful for low copy transcripts where there is a risk of high background. 
The PCR conditions for the PCR DIG labelling mix are the same compared to 
conditions established for a defined primer/template pair. The reaction components, 
shown in Table 2.7, were added to a sterile, microcentrifuge tube at 4°C: 
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Table 2-7 Reaction mixes for PCR DIG probes 
Reagents Volume Final concentrations 
Sterile, deionised water variable - 
PCR buffer, lox conc.,l5mM M902  10111 1.5mM MgCl2 
PCR DIG labelling mix lOiil 200j.tM dNTP 
Primer 1 1111 O.l-ljiM 
Primer  1111 0.1-lj.tM 
Taq DNA polymerase 0.2-ijil 1-5U/1001i1 
Template DNA variable variable 
Total 100111 
2.5.7.2 In situ Hybridisation 
Ovaries from female OrR Drosophila were dissected in Ringer's solution and 
transferred into imI pp (fix) and incubated at room temperature for 1-1.5 hours with 
gentle mixing (on a whiny wheel). The ovaries were washed 3x 10 minutes in PBT to 
remove the fix, then incubated in 9:1, rnethanol:EGT& (0.5M, pH 8) for 10 minutes, 
and washed again 3x 10 minutes in PBT. This was followed by proteinase K (Sigma, 
lOO.ig/rnl in PBT) treatment for 1 hour at 18°C, which was stopped by 2x 5 minute 
washes in PBT. The ovaries were then post-fixed for 20 minutes in pp and washed 
6x 5 minutes with PBT. 
The ovaries were equilibrated for 10 minutes in 200111 1:1, PBT:hybrix and 
prehybridised with 100111 hybrix for at least 1 hour at 45°C (in a heating block). The 
prehybridisation step can be extended to reduce background if necessary. Following 
this, the ovaries were hybridised with the digoxygenin labelled probe, dissolved in 
hybrix, at 45°C overnight. 
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After hybridisation, the ovaries were washed (with pre-warmed wash solutions) 2x 
20 minutes at 45°C with 500jil hybrix, then 3x 20 minutes at 45°C with 500111 1:1, 
PBT:hybrix, 3x 20 minutes at 45°C with 500tl PBT and finally 5x 5 minutes at room 
temperature with PBT and gentle shaking. Signals were detected by incubation with 
irni Alkaline phosphatase (AP) conjugated anti-digoxygenin antibody (antibody 
diluted 1:1000 in PBT, and preabsorbed before use with post-fixed ovaries overnight 
at 4°C) at room temperature for 1.5 hours. Excess antibody was removed by washing 
the ovaries 3x 20 minutes in PBT with gentle shaking. If necessary the ovaries were 
stored overnight at 4°C before developing. 
The ovaries were equilibrated by washing 3x 5 minutes in NMTT (made fresh). The 
ovaries were incubated in the dark in lml NMTT containing 3.5111 X-phosphate and 
4.5111 NBT. The signal was developed for 15 minutes to several hours, depending on 
the staining intensity. The colour reaction was stopped by 3 rinses in PBT, the 
ovaries were mounted and observed under the microscope. 
Unless stated otherwise the steps were carried out at room temperature 
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CHAPTER 3 
RESULTS 
Regulation of yp3 in the fat body 
3.1 INTRODUCTION 
Although yp] andyp2 gene expression has been investigated in some detail, this is not 
the case for yp3. Due to the expression patterns of ypi, yp2 and yp3 being so highly 
co-ordinated it is likely that the factors involved in the transcriptional regulation of 
all threeyp genes are very similar. A 419bp DNA fragment, termed FBE3, located 5' 
of the transcription start site of Drosophila yp3, was found to direct lacZ expression, 
in the fat body of females, but not males (Ronaldson and Bownes, 1995). This 
fragment was used for further investigation: to identify trans-acting factors binding to 
the FBE3, to narrow the size of the region down and to consider its transcriptional 
regulation ofyp3. 
3.2 ANALYSIS OF CIS-ACTING FRAGMENTS REQUIRED FOR FEMALE-, 
FAT BODY-SPECIFIC EXPRESSION 
3.2.1 The pERI Transformation vector 
DNA fragments were cloned into the transformation vector pERI; a map of the 
vector is shown in Figure 3.1 and construction of the vector is reported in Ronaldson 
and Bownes (1995). The pERI vector is a modification of the pCaspeR-AUG-j3gal 
vector and contains a Drosophila hsp70 promoter fragment. This allows fragments 
lacking the yp3 promoter to be tested for their effects on reporter gene activity. 
Unique restriction sites in pERI for cloning constructs to be tested were EcoRI and 
XhoI positioned 5' of the hsp70 promoter, and BamFil positioned 3' of the promoter. 
A diagram of the pERI transformation vector is shown in Figure 3.1. 
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Figure 3.1 
Structure of the pERI transformation vector. The pCaSpeR-AUG-J3gal vector was 
modified to contain a 282bp hsp70 promoter fragment. Unique cloning sites are 
EcoPJ (E) and fbI (Xh) upstream of the hsp70 sequence, and BamHI (B) 
downstream of the hsp70 promoter. The size of the vector is 12.5kb. The vector 
construction is detailed in Ronaidson and Bownes, 1995. 
Unshaded boxes at the HindIII sites (H) indicate P-element ends. The white gene is 
transcribed in the opposite direction to the lacZ reporter gene, arrows show the 





3.2.2 Construction and Analysis of the Reporter Constructs 
The yp3 regions tested for the presence of enhancer elements are illustrated in Figure 
3.2. A pBluescript (Stratagene) plasmid, containing the 419bp yp3 upstream 
fragment found to direct lacZ expression in the fat body of females, was used to 
generate fragments for subcloning. The 419bp DNA fragment, termed FBE3, had 
been cloned into the EcoFJ site in pBluescript by the addition of EcoRI linkers, 
named yp3/9 (E. Ronaldson, personal communication). 
A 246bp subfragment from FBE3, spanning nucleotides -528 to -282, was isolated 
using the polymerase chain reaction (PCR), and this PCR product had been designed 
to give EcoRl restriction sites at each end. The PCR product was digested with 
EcoRI and cloned into pERI cut with EcoRI and CLAP treated (to prevent vector 
religation). This allowed the 246bp fragment to be cloned in both forward and reverse 
orientations, which were verified by sequencing. The sequence of the PCR product 
was also checked to confirm that no mutations had been introduced by the PCR 
reaction. Construct A was the 246bp PCR fragment in the forward orientation and 
construct B the reverse orientation. Constructs C and D contained a smaller upstream 
region of 177bp (-704 to -527), in forward and reverse orientations respectively. The 
1 77bp fragment was isolated by a EcoRl and Sau3AI digestion, then cloned into 
pBluescript cut with EcoRI and Ba,nHI. The fragment was excised with XbaI and 
XhoI, Klenow treated to create blunt ends and cloned into pERI, which had been cut 
with EcoRI, Kienow treated to create blunt ends and CLAP treated. Constructs E and 
F were created by digesting yp3/9 with RsaI to yield a blunt ended 250bp fragment, 
which was cloned into pBluescript cut with EcoRV. The fragment was then excised 
by digestion with EcoRI and cloned into pERT, which had been cut with EcoRT and 
CLAP treated. This generated constructs with the inserts in both orientations, 
however, when sequenced the inserts were found to have varying lengths; some were 
206bp and others 190bp in length. Single copies of the fragment in pERT were only 
found in the forward orientation for the 206bp insert (construct E) and the reverse 
orientation for the 190bp insert (construct F). It is not known why the procedure 
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Figure 3.2 
A summary of the yp3 constructs tested for transcription enhancer elements 
regulating yp3 fat body expression. At the top is a schematic diagram of the yp3 gene 
showing the 419bp region found to be capable of directing female- and fat body-
specific yp3 expression. 
The hatched boxes represent introns within the yp3 coding sequence. Transcripts and 
their direction of transcription are represented by arrows. The sizes (in bp) of the 
yp3 fragments used in reporter constructs are indicated below the constructs, the 
nucleotide positions in relation to the yp3 transcription start site and the orientation 
of the fragments are indicated above. 
ATG 
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-527 	-704 [ 
D 	
177bp 
1 hsp70-lacZ 	 I 
-704 	-498 
B 	 hsp70-iacZ 
206bp 
-514 	-704 
F 	 hsp70-lacZ 
l9Obp 
generated fragments of unequal length. All constructs were sequenced to check 
orientation, position and size, a summary of this information is shown in Table 3.1. 
Table 3.1 Summary of constructs used to analyse yp3 fat body regulation 
Size (bp) Position relative to yp3 start site Orientation 
Start Finish 
FD 
246bp -528 -282 Forward 
246bp -528 -282 Reverse 
177bp -704 -527 Forward 
177bp -704 -527 Reverse 
E 206bp -704 
F 
-498 Forward 
190bp -704 -514 Reverse 
All constructs were introduced into the Drosophila germline using standard 
transformation techniques (Rubin and Spradling, 1982), detailed in section 2.5.3.1. 
As many independently transformed lines as possible were assayed for each 
construct tested, a summary of the number of lines produced for each construct is 
shown in Table 3.2. Male and female fat bodies were dissected and used for 
histochemical staining to determine the ability of each construct for yp3 regulation. 
Reporter gene expression was detected by blue colouration produced by j3- 
galactosidase activity and the effects of each construct were analysed. All body parts 
were used for staining to compare position effects between constructs (discussed in 
section 1.4). Because the transformed constructs were not used for quantitative 
assays, merely the presence or absence of 3-galactosidase activity, the transformed 
lines were not analysed for the copy number of constructs they contained. If the 
transformed lines were used for quantitative assays in the future, the construct copy 
numbers would be analysed and single copy inserts used. 
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Table 3.2 The number of transformed lines obtained for each construct tested 







The 419bp FBE3 was found to direct reporter gene expression in a sex- and tissue-
specific pattern; to the female fat body. Flies transformed with constructs containing 
the different fragments derived from the 419bp FBE3, were stained for I-
galactosidase activity to identify which fragments were capable of directing this 
pattern of reporter gene expression. Table 3.3 shows a summary of the reporter gene 
expression patterns found in the fat body cells of each transformed line analysed. 
Constructs A and B, containing the 246bp fragment in forward and reverse 
orientations, were found to be unable to direct reporter gene expression in the female 
fat body, shown in Figure 3.3. 
Constructs C and D, containing the 177bp fragment in forward and reverse 
orientations, were found to give two different classes of transformant, these results 
are shown in Figure 3.4. In some lines the 1 77bp fragment was found to direct 
reporter gene expression in the fat body cells, but this was not limited to females 
only; both male and female fat bodies showed staining (Figure 3.4A and B). In 
transformed lines that showed reporter gene expression, staining was always in both 
sexes. Other lines showed no staining in the fat bodies of either sex, shown in Figure 
3.4C and D. 
Constructs E and F were created to extend the length of the 177bp fragment to 
determine if consistent female- fat body-specific expression could be resumed, 
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Figure 3.3 
Photographs illustrating the -galactosidase activity observed in Drosophila fat body 
cells transformed with constructs A and B containing 246bp of yp3 upstream 
sequence. Reporter gene expression, and thus 13-galactosidase activity, is shown when 
tissues are stained with X-Gal and produces a blue colouration. 
X-Gal stained female abdomen (A) and male abdomen (B) of line (SH3)2D4B, typical 
of lines transformed with constructs A and B, showing an absence of staining or 
reporter gene activity. 
Constructs A and B are shown in diagram C, below the photographs. 
C 	 +1 	yp3 
	
-704 	 -285 
I I 








Photographs illustrating the -galactosidase activity observed in Drosophila fat body 
cells transformed with constructs C and D containing 1 77bp of yp3 upstream 
sequence. 
Line (SF18) 1 D5A, transformed with the 1 77bp fragment, shows reporter gene 
expression in the fat bodies of females (A) and also males (B). Other independently 
transformed lines containing the 177bp fragment also showed the same expression 
pattern, but there were also lines that did not show reporter gene expression in either 
female (C) or male fat bodies (D), shown by line (SI-18)51-2 in this example. 
Expression in flies transformed with constructs C and D either had reporter gene 
expression in both sexes or neither sex. 
Constructs C and D are shown in diagram E, below the photographs. 
A B 
—w—.  - 
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c 	-704 	-527 hvp70-lacZ 
because there was a possibility that the isolation of the 177bp fragment could have 
disrupted any binding sites located at the 3' end, around position -527. 
Of the two fly lines transformed with construct E, containing a 206bp fragment, one 
line showed reporter gene expression in the fat bodies of both males and females, and 
the other line gave no staining in the fat body of either sex (Figure 3.5). Only one 
transformed line was created containing construct F (1 90bp fragment) which showed 
reporter gene expression in the fat bodies of both males and females (Figure 3.6). The 
addition of 29bp and 13bp to the 177bp fragment does not appear to be sufficient to 
regain sex-specificity of the reporter gene expression. 
Table 3.3 Summary of the -galactosidase staining patterns obtained with the 
transformed lines analysed 
Construct 
Frelix 
 code Line numbers 
[ 	
Staining in fat body cells 
A SH3 1D2A, 2D4A, 2D4B, 2D4C, 
3D5A 
no 
B SF14 1D5A, 1D5B, 1D5C, 1D5D, 
1DSE, 1D5F 
no 
C SH8 ID4A, 48-2, 51-2, 51-4 no 
1D5A, 1D5B, 1D5C, 1D5D, 
3D5A, 1-1, 26-1, 48-1 
yes, in males and females 
D SH7 2-1, 5-3, 10-1, 10-6, 12-6, 
44-1,42-1, 
no 
3-1, 4-1, 5-1, 10-4, 11-1, 
12-2, 18-2, 34-1 
yes, in males and females 
E r5 2-1 no 
-1 yes, in males and  
F r2 1-1 yes, in males and 
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Figure 3.5 
Photographs illustrating the 3-galactosidase activity observed in Drosophila fat body 
cells transformed with construct E containing 206bp of yp3 upstream sequence. 
Only two independently transformed Drosophila lines were obtained with construct 
E. Line (r5)1-1 showed reporter gene expression, and thus 3-galactosidase activity, in 
the fat bodies of females (A) and also males (B). The other independently 
transformed line containing the 206bp fragment, line (r5)2-1, did not show reporter 
gene expression in either female (C) or male fat bodies (D). 
Expression in flies transformed with construct E either had reporter gene expression 
in both sexes or neither sex. 
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Figure 3.6 
Photographs illustrating the 3-gaIactosidase activity observed in Drosophila fat body 
cells transformed with construct F containing 190bp of yp3  upstream sequence. 
Only one transformed Drosophila line was obtained with construct F. This line 
(r2)1-1 showed reporter gene expression in the fat body cells of both males and 
females. 
Construct F is shown in diagram C, below the photographs. 
IM 
L 
C 	 +1 	yp3 
	
-704 	 -285 
SstI 	419bp 	Asp700 
F 	-514 	-704 
3.2.3 Conclusion 
A 246bp fragment, spanning nucleotides -528 to -282, was unable to direct reporter 
gene expression in the female fat body when transformed into flies. 
A 177bp fragment, spanning nucleotides -704 to -527, was found to be capable of 
directing reporter gene expression in fat body cells, but expression was not sex-
limited and occurred in both males and females, or neither sex. 
Increasing the I 77bp fragment to 206bp did not restore the reporter gene expression 
in the fat body to females only, expression was either in both sexes or not at all, and 
the one transformed line containing a 1 9Obp fragment gave staining in both sexes. 
3.3 DOUBLESEX GEL RETARDATION ASSAYS 
Sex determination in Drosophila involves a hierarchy of regulatory genes, the 
expression of which depends UOfl the ratio of X chromosomes to autosornes. The 
cloublesex gene is the final gene in the regulatory pathway and encodes both male-
specific and female-specific polypeptides, whose synthesis is regulated by 
alternative sex-specific splicing of the primary dsx transcript. The only target genes 
shown to be under direct control of the sex determination hierarchy are the yolk 
protein genes, specifically ypi and yp2 (Burtis et al., 1991). 
The male-specific and female-specific forms of the doubiesex polypeptide, DSXM 
and DSXF  respectively, have amino acid sequences common to both. They have 
identical N-termini of 397 amino acids which contain a zinc finger-related DNA 
binding domain (Erdman and Burtis, 1993) and it has been established that the DSX 
proteins can act as DNA binding transcription factors. The C-termini are different 
due to the alternative splicing of the dsx transcript and are either I 52aa (DSXM)  or 
30aa (DSX). 
Both DSXM  and DSX' are able to bind in vitro to the 125bp FBE of yp] and yp2 
(Burtis et al., 1991).The DSX proteins bind to four sites within the FBE. DSXM 
represses and DSX F  activates transcription from the two strongest binding sites 
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(Coschigano and Wensink, 1993). Genetic evidence shows that the DSX proteins 
confer the sex-specificity of the yolk protein gene expression such that there is 
expression in the fat body of females, but not males. 
One of the aims of this project was to determine if the DSX proteins could bind to 
the 41 9bp FBE3 found to direct lacZ expression in the fat body of females, and 
smaller subfragments of this region. 
The DNA-protein binding assay is a sensitive method for the detection of sequence-
specific DNA-binding proteins. Proteins that bind specifically to a radioactive end-
labelled DNA fragment retard the mobility of the fragment during polyacrylamide gel 
electrophoresis, the positions of which can be viewed on an autoradiograph of the 
gel. 
3.3.1 Preparation of DSX protein extracts 
A pGEX T7 expression vector containing the N-terminal DNA binding domain 
common to both DSXM  and  DSXF  proteins (amino acids 1-397) was used to express 
this domain as a g!utathione-S-transferase (GST) fusion protein, for use in gel 
retardation assays. The vector, named pGEX-KG, was a gift from K. Burtis 
(University of California). The method for DSX DNA binding domain protein 
expression and purification was adapted from Erdman and Burtis (1993), and is 
detailed in section 2.5.4, materials and methods. The purified GST-DSX was 
dialysed in Z-50 buffer for use in the gel retardation assays. An example of the 
protein purification stages run on SDS-PAGE is shown in Figure 5.1 in Chapter 5. 
3.3.2 Gel retardation assays with 419bp FBE3 
Gel retardation assays were carried out with the 419bp FBE3 and purified DSX 
DNA binding domain protein extracts. The 419bp fragment was excised from yp3/9 
by an Xhal and XhoJ restriction digest and end-labelled with 32P, using Klenow to 
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make a probe and purified prior to use. The experimental procedures used for the gel 
retardation assays were modified from Burtis et at., 1991. 
Preliminary experiments were carried out to determine the levels of non-specific 
competitor DNA polydldC required to eliminate excess binding of protein to the 
probe. An example of these results for the 419bp FBE3 is shown in Figure 3.7A. In 
the gel retardation assays with the FBE3, lOng of probe and -2ig purified DSX were 
used in each reaction, and the amount of polydldC varied between lOOng and 2J.ig, 
lanes 3 to 7. A control reaction was included that contained a protein extract from 
E. co/i transformed with the pGEX vector without the dsx insert. The reactions were 
incubated at room temperature for 30 minutes and under these binding conditions, the 
presence of polydldC eliminated any non-specific binding to give a mobility shift of 
the FBE3 with the DSX binding domain protein. 250ng polydldC was enough to give 
a clear gel shift band, the position of which is shown by an arrow in Figure 3.7A, and 
further increases in polydldC did not appear to have any further effect. 
To demonstrate the specificity of interactions between the FBE3 and the DSX 
binding domain protein, gel retardation assays were performed including a synthetic 
29bp competitor oligonucleotide, containing the highest affinity binding site for the 
DSX protein, "dsx A" in the FBE (An and Wensink, 1995a). The sequence of this 
oligonucleotide is GTG CAC AAC TAC AAT GTT GCA ATC AGC GG. The 
reactions were based on those above, but reactions other than the free probe 
contained 200ng polydldC. An example of these results is shown in Figure 3.713. The 
419bp FBE3 does not shift with the E. co/i control extract, lane 2, but will shift with 
DSX in the presence of 4tg and lO.tg polydldC, molar excesses of 2900X and 
14500X respectively, lanes 3 and 4 (gel shift position marked with an arrow). 
Competition by the "dsx A" oligonucleotide, at molar excesses of 2900X and 
14500X, led to the disappearance of the protein-DNA complexes, lanes 5 and 6, 
confirming the presence of specific DSX binding sites within the 419bp FBE3 
fragment. 
Sometimes extra bands could be seen in the end labelled probes, it is not known 
exactly what these bands are, but they could be more than one fragment joined 
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Figure 3.7A 
Autoradiograph of gel retardation assays with 419bp FBE3. 
Lane I represents free probe; unbound DNA. A control was performed using an E. 
co/i cell extract, lane 2. The probe was incubated with DSX binding domain protein 
and increasing amounts of polydldC, lanes 3 to 7. The gel shift position is marked 
with an arrow. 
The components of each reaction (buffers and reaction volumes are detailed in section 
2.56) are shown in the following table: 
Lane Probe Amount of DSX Amount of 	polydldC 
protein E. coli extract 
1 lOng - - 
2 lOng - 2.ig 	 250ng 
3 lOng 2ig - 	 lOOng 
4 lOng 2ig - 	 250ng 
5 lOng 2tg - 	 500ng 
6 lOng 2g - 	 lig 
7 lOng 2p.g - 	 2tg 
Figure 3.7B 
Autoradiograph of gel retardation assays with 419bp FBE3. 
Lane I represents free probe; unbound DNA. A control was performed using an E. 
coil cell extract, lane 2. Lanes 3 and 4 contained increasing amounts of non-specific 
competitor, polydldC. Lanes 5 and 6 contained increasing amounts of specific 
competitor, the synthetic oligonucleotide for the DSX binding site, "dsxA". The gel 
shift position is marked with an arrow. 
The components of each reaction (buffers and reaction volumes are detailed in section 
2.5.6) are shown in the following table: 
Lane Probe Amount of 	Amount of polydldC Synthetic 
DSX protein 	E. coli extract Oligonucleotide 
lOng - 	 - - - 
2 lOng - 	 2jig 2jig - 
3 lOng 2jig - 4tg - 
4 lOng 2j.tg 	 - lO.tg - 
5 lOng 2tg - 2p.g 2j.ig 
6 1 Ong 2tg 	 - 2p.g 1 Ogg 
1 	2 	3 	4 	5 	6 	7 
specific competitor 
LIJ 






together, possibly created during the labelling reaction. In Figure 3.713, the free probe 
(lane 1) has an extra band which is larger than the 41 9bp fragment, this fragment also 
appears to bind DSX protein and forms two DNA-protein complexes, located at the 
top of the gel in lanes 3 and 4. These complexes are also competed away by the 
addition of"dsxA" oligonucleotide, lanes 5 and 6. If the extra fragment is a multiple 
of the 41 9bp fragment it will also have more than one DSX binding site, and the 
presence of two DNA-protein complexes could be due to differing numbers of DSX 
protein molecules binding to this fragment. 
3.3.3 Gel retardation assays with 177bp and 250bp FBE3 subfragments 
The 41 9bp FBE3 was divided into two smaller fragments; a I 77bp fragment (-704 to 
-527) and a 246bp fragment (-528 to -282), these are also the same fragments tested 
for their yp3 enhancer capabilities in section 3.2.2. These fragments were cloned into 
pBluescript and excised for use as gel shift probes with an XbaI and XhoI restriction 
digest. 
Reaction conditions used in the gel retardation assays with the FBE3 were used again 
for the smaller subfragments, lOng of probe and -2p.g purified DSX were used in 
each reaction. Preliminary experiments with the 1 77bp fragment showed a gel shift 
with the DSX binding domain protein, marked with an arrow in Figure 3.8A, which 
remained as the level of polydldC was increased from lOOng to 2p.g, lanes 3-8. Lane 2 
is a control reaction with an E. coli protein extract that does not contain the dsx 
insert, and thus does not give a gel shift. 
The gel shift was shown to be a specific interaction between the 1 77bp fragment and 
the DSX binding domain by specific competition with the "dsx A" synthetic 
oligonucleotide. An example of these results is shown in Figure 3.813. The gel shift 
was competed away with the addition of the "dsx A" oligonucleotide, at molar 
excesses of 1 200X and 61 OOX, lanes 5 and 6, thus confirming the 1 77bp fragment 
contains a specific DSX binding site. The addition of non-specific competitor, 
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Figure 3.8A 
Autoradiograph of gel retardation assays with I 77bp fragment of FBE3. 
Lane 1 represents free probe; unbound DNA. A control was performed using an E. 
co/i cell extract, lane 2. The probe was incubated with DSX binding domain protein 
and increasing amounts of polydldC, lanes 3 to 8. The gel shift position is marked 
with an arrow. 
The components of each reaction (buffers and reaction volumes are detailed in section 
2.5.6) are shown in the following table: 
Lane Probe Amount of DSX Amount of 	polydldC 
protein E. coli extract 
1 lOng - - 
2 lOng - 2tg 	 250ng 
3 lOng 2jLg - 	 lOOng 
4 lOng 2jig - 	 250ng 
5 lOng 4tg - 	 SOOng 
6 lOng 2p.g - 	 lp.g 
7 lOng 2g - 	 1.5tg 
8 lOng 2jig - 	 2.tg 
Figure 3.8B 
Autoradiograph of gel retardation assays with 177bp fragment of FBE3. 
Lane 1 represents free probe; unbound DNA. A control was performed using an E. 
co/i cell extract, lane 2. Lanes 3 and 4 contained increasing amounts of non-specific 
competitor, polydldC. Lanes 5 and 6 contained increasing amounts of specific 
competitor, the synthetic oligonucleotide for the DSX binding site, "dsxA". The gel 
shift position is marked with an arrow. 
The components of each reaction (buffers and reaction volumes are detailed in section 
2.5.6) are shown in the following table: 
Lane Probe Amount of 	Amount of polydldC Synthetic 
DSX protein 	E. co/i extract Oligonucleotide 
I lOng - 	 - - - 
2 lOng - 	 2jig 2.tg - 
3 lOng 2jg - 2.tg - 
4 lOng 2jig 	 - lOjig - 
5 lOng 2ig - 2jtg 2ig 
6 1Ong 2ig 	 - 2ig lOjig 
A 	 non-specific competitor 
pdldC 
B 	 specific competitor 
pdldC 	synthetic oligonucleotide 
-. 
1 	2 	3 	4 	5 	6 
polydldC, to molar excesses of 1200X and 6100X had no effect upon the DNA-
protein complexes, shown in lanes 3 and 4. 
Preliminary experiments with the 246bp fragment revealed that it does not appear to 
have DSX binding capabilities. Reactions contained 1 Ong of probe and '-.2.tg purified 
DSX, and the amount of polydldC varied between 1 OOng and 2ig. The results for 
this experiment are shown in Figure 3.8C. As the amount of polydldC increases non-
specific protein binding is eliminated, but there is no specific binding occurring with 
DSX to give a gel shift. With the 419bp FBE3 and the 177bp fragment, 250ng 
polydldC was sufficient to show a clear gel shift, for the 246bp fragment, 250ng 
polydldC gives a smeared lane on the gel (lane 4) as a result of non-specific DNA-
protein binding. 
3.3.4 Conclusion 
The 41 9bp FBE3 was found to be capable of forming a specific complex with DSX 
binding domain protein in vitro. This 41 9bp fragment was divided into two smaller 
subfragmcnts of 1 77bp and 246bp. The 1 77bp fragment was also found to bind 
specifically to the DSX binding domain protein in gel retardation assays. The 246bp 
fragment was not capable of binding to DSX binding domain protein in vitro. 
These results indicate that the 41 9bp FBE3 contains a DSX binding site and this 
binding site is located between positions -704 to -527. 
It should also be noted that there may be more than one DSX binding site located 
within the 177bp fragment, considering that three sites were found in the FBE of yp] 
and yp2. However, if there are multiple sites, they all appear to bind to the same 
number of DSX molecules in the assays because multiple gel shift bands are not 
observed for single copies of the 419bp and 177bp fragments. 
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Figure 3.8C 
Autoradiograph of gel retardation assays with 246p fragment of FBE3. 
Lane I represents free probe; unbound DNA. A control was performed using an E. 
coli cell extract, lane 2. The probe was incubated with DSX binding domain protein 
and increasing amounts of polydldC, lanes 3 to 8. 
The components of each reaction (buffers and reaction volumes are detailed in section 
2.5.6) are shown in the following table: 
Lane Probe Amount of DSX Amount of 	polydldC 
protein E. coli extract 
1 lOng - - 
2 lOng - 2.tg 	 250ng 
3 lOng 2pg - 	 lOOng 
4 lOng 2ig - 	 250ng 
5 lOng 2.tg - 	 SOOng 
6 lOng 2ig - 	 lig 
7 lOng 2g - 	 1.5.tg 
8 lOng 2'g - 	 2jig 
C 
	 non-specific competitor 
pdldC 
2 	3 	4 	5 	6 	7 
3.4 THE EFFECT OF C/EBP MUTANTS ON VP PROTEIN EXPRESSION 
The I 25bp FBE from the intergenic region of ypi and yp2 has been used in 
footprinting assays to identify transcriptional regulatory proteins implicated in the 
control of fat body-specific yp gene expression (Abel et al., 1992; Falb and Maniatis, 
1992). One of these was the CCAAT/enhancer-binding protein (C/EBP) from rats, 
which was found to have an overlapping recognition site with the adult enhancer 
factor-i (AEF-1), which has been isolated from Drosophila. They are thought to 
bind competitively creating a possible activation (C/EBP)/repression (AEF-l) 
mechanism, since AEF-1 can inhibit binding of C/EBP and thereby repress its 
activating potential (Falb and Maniatis, 1992). 
The Drosophila homologue of C/EBP (DmC/EBP) has since been identified and is 
encoded by the slow border cells (s/ho) gene (Montell ci al., 1992). The sibo gene 
encodes a CCAAT/enhancer-binding protein, a basic region-leucine zipper 
transcription factor, which is a member of the bZIP family of proteins. The sibo gene 
was identified as a result of a screen for P-element insertion mutations that 
specifically blocked border cell migration  during oogenesis. Deletion of the sibo gene 
results in late embryo lethality; embryos that lack C/EBP die just before or upon 
hatching. P-element insertion in s/ho delays border cell migration, but all other 
aspects of oogenesis appear normal and the observed female sterility is caused by 
eggs remaining unfertilised. The micropyles of these s/ho eggs appeared to lack a pore 
canal and their tips were defective and misshapen, resulting in the sibo eggs being 
unfertilised (Rorth and Montell, 1992). 
Mutations in the s/ho gene had been produced by P-element insertion and also by the 
subsequent excision of these P-elements (Montell ci al., 1992), and these mutants 
were used in this project to investigate their effect on YP protein expression. 
Specifically to determine if Drosophila CIEBP is the bZIP protein responsible for 
activating YP protein expression in the female fat body, by comparing the YP protein 
levels between heterozygote and homozygote s/ho mutants. 
86 
CHAPTER THREE: REGULATION OF YP3 IN THE FAT BODY 
Two siho mutants were used: 
1(2)sIboe 7b 	 s/ho deletion, homozygous lethal 
fs(2)sIbo' 8 	rosy+ insertion, female sterile 
Heterozygous virgins, with the curly wing marker (CyO), were collected for each 
mutant and crosses set up between opposite sexes of each line. 
cross: 	l(2)slh0c7b 	X 	fs(2 )s1bo' 8 
CYO 	 CYO 
trans-heterozygotes: 	l(2)s1b0c7b 
fs(2)s1bo'' 8 
The progeny from these crosses were collected daily and aged for three days, for 
vitellogenesis to be occurring, before haernolyrnph samples were taken. The 
haemolymph contains YPs synthesised in the fat body and thus can be used to 
assess the levels of Yps produced. Samples were taken from heterozygous males, 
heterozygous females and trans-heterozygous females (straight wing phenotype). 
Approximately 20-30 flies were used for each sample, the haernolyrnph was pooled 
in 25il Ringer's solution on ice, then stored at -20°C. The protein concentration of 
each sample was measured using the Bradford assay, then approximately 8ig of 
protein for each sample was used for SDS-PAGE analysis. Proteins were visualised 
using the ISS Pro-Blue staining system, an example of which is shown in Figure 3.9. 
These protein gels were scanned using a Shimadzu dual-wavelength chromato scanner 
(CS-930), the three \TP  protein bands plus two other bands in each sample were 
scanned to obtain values for the percentage of the sample each protein occupied. The 
percentage of YP proteins were then compared between heterozygote and trans- 
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Figure 3.9 
Polyacrylamide gel stained with ISS Pro-Blue. 
Haemolymph samples were taken from heterozygous sibo males (lane 1), 
heterozygous sibo females (lane 2) and homozygous sibo females (lane 3). Each lane 
contained approximately 8p.g of protein. 
The positions of the YPs are indicated with arrows. 
C/EBP 	C/EBP 
cfr 	+ C/EBP 
heterozygote sibo mutants. This experiment was repeated three times to obtain 
average values for the YP percentages and the 95% confidence limits were calculated: 
slbo heterozygous mutants 	65.3 ± 7.75 
sibo trans-heterozygous mutants 	72.9 ± 2.88 
This indicates that the 95% confidence limits overlap between the two samples and 
thus the true means for each sample may not be significantly different, this was also 
confirmed by a t-test. 
3.4.1 Conclusion 
Trans-heterozygote mutants in the sibo gene (Drosophila C/EBP) were not found to 
have significantly different levels of the YPs in their haemolymph when compared to 
heterozygote slbo mutants. These results indicate that Drosophila C/EBP is unlikely 
to be an activator of yp expression in the female fat body. It would be expected that 
the loss of an activator of the yps would decrease transcriptional activation resulting 
in less YP protein expression, but this observation was not made. However, it should 
be noted that this experiment has limitations to its interpretation because the degree 
of penetrance for each of the slbo mutants is not known and there are also steps 
within the procedure at which variability may occur. 
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3.5 IDENTIFICATION OF PUTATIVE TRANSCRIPTION FACTOR 
BINDING SITES 
Since the yps are coordinately transcribed, it is likely that the mechanisms and factors 
involved will be the same for all three genes. The footprint sequences identified for 
AEF-1, CIEBP and DSX in the FBE of ypi and yp2 were used in computer searches 
to determine their putative binding sites in the FBE3 sequence, comparisons were 
also made between theyp] and yp2 FBE and the FBE3 of yp3. The Bestfit and Gap 
search programs (University of Wisconsin Computer Genetics Group (GCG) 
software, Devereux et al, 1984) were used to identify regions of sequence homology. 
The results of the searches are shown in Figure 3.1OA. The best sequence similarity 
was found to be with the AEF- 1 and C/EBP overlapping footprint contained within 
the 125bp FBE (Falb and Maniatis, 1992), the yp3 sequence has 75% identity to a 24 
nucleotide footprint sequence, including a gap of 4 nucleotides. If the gap is excluded 
the similarity is 90% between the matched sequences. The yp3 region -504 to -523 
containing this homology is present in the 206bp yp3 fragment in construct E, but is 
not contained within the 177bp fragment in constructs C and D. Figure 3.11 shows 
how the regions of sequence similarity are located relative to constructs A to F. 
A 9bp DSX consensus binding site sequence (reverse complement) was found to give 
a 7 nucleotide match to a region of yp3, shown in Figure 3.1OB. This putative DSX 
binding site is located within the 177bpyp3 fragment that was found to gel shift with 
the DSX binding domain, this was also the nearest site to the overlapping AEF-1 and 
C/EBP region of homology (Figure 3.11). However, many putative DSX binding sites 
are possible because the consensus sequence is short and several yp3 regions show 
homologies with the computer search. 
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Figure 3.I0A 
Region of the 419bp yp3 FBE3 with sequence similarity to the AEF-1 and C/EBP 
binding sites located in the FBE of yp] and yp2. The vertical lines represent 
nucleotide identities, and the degree of similarity between the two sequences is also 
indicated. 
Figure 3.108 
The computer sequence homology in the 419bp yp3 FBE3 to a 9bp DSX consensus 
binding site sequence (reverse complement). 













-523 	 -504 
yp3  FBE 
[öl 
yp3  FBE 




1 	 S 
DSX consensus binding site sequence 
Figure 3.11 
Diagram to show the location of sequence similarities in the 419bp yp3 FBE3 to 
transcription factor binding sites previously identified within the yp] and yp2 FBE. 
The locations of these sequence similarities are shown in relation to constructs A to 
F. 
+1 	 yp3 
-704 	DSX AEF-1/CEBP 	 -285 
246bp 	
Constructs A and B 
-528 	 -285 
177bp 	
Constructs C and D 
-704 	 -527 
206bp 
-704 	 -498 
Construct B 
I9Obp 
-704 	 -514 
Construct F 
3.6 SUMMARY AND DISCUSSION 
The 41 9bp FBE3 of yp3 was subdivided into smaller fragments and the following 
observations were made: 
A 246bp fragment, spanning nucleotides -528 to -282, was unable to direct reporter 
gene expression in the female fat body when transformed into flies, and did not give a 
gel shift with DSX binding domain protein. 
A 1 77bp fragment, spanning nucleotides -704 to -527, was found to be capable of 
directing reporter gene expression in fat body cells, but expression was not sex-
limited and occurred in both males and females, or neither sex. This 177bp fragment 
was found to bind specifically to the DSX binding domain protein in gel retardation 
assays. 
Increasing the 1 77bp fragment to 206bp did not restore the reporter gene expression 
in the fat body to females only, expression was either in both sexes or not at all. The 
29bp addition to the 1 77bp fragment (to give 206bp) contained a region of homology, 
identified by computer searches, to the footprints of AEF-1 and C/EBP for the FBE 
of ypi and yp2. The one transformed line containing a 190bp fragment gave staining 
in both sexes. 
The role of Drosophila C/EBP as an activator of yp expression was investigated. 
Trans-heterozygote mutants in the sibo gene (Drosophila C/EBP) were not found to 
have significantly different levels of the YPs in their haemolymph when compared to 
heterozygote sibo mutants. 
It is useful to compare these results to the work that has already been performed 
with the FifE of yp] and yp2 (previously detailed in Chapter U;  it has always been 
predicted that all three yolk protein genes would share similar, if not identical, 
regulatory mechanisms. 
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A model was proposed for the regulation of ypl12 in the female fat body (An and 
Wensinic, 1995b). A small enhancer, o-r, located in the intergenic region of ypi and 
yp2, was found to direct female- and fat body-specific transcription in a similar 
pattern to the yp genes (An and Wensink, 1995a). The o-r enhancer contains four 
protein binding sites positioned in two enhancer elements; the Q element consists of 
three overlapping binding sites: dsxA which binds the female (DSXF)  and male 
(DSXM) forms of Doublesex protein, the aefi site which binds the AEF-1 repressor 
and the bzipl site which is capable of binding DmC/EBP. The r element is a single 
site, named refi, which is postulated to bind an unidentified activator. Germline 
transformation experiments showed neither o nor r can activate transcription by 
themselves, but together in single copy they direct transcription in female fat bodies 
only. The o-r enhancer was manipulated to create multimeric and mutated binding 
sites for each of the four protein binding sites, which were used in protein binding, 
germline transformation and genetic experiments to examine both the independent and 
combined activities of the proteins and their binding sites. This led to the proposal of 
a model for the regulation of yp112 by the o-r enhancer, a summary diagram is shown 
in Figure 3.12. 
Model for the regulation of yp112 by the o-r enhancer: 
In female fat bodies, the DSXF  and bZIP proteins activate synergistically, possibly 
by co-operative binding or by altering bZIP activity upon its binding to the site. The 
bZIP also acts cooperatively with an activator at the refl site to yield gene 
expression in the female fat body. DSXF  also interferes with the binding of AEF-1 
and prevents it repressing transcription in female fat bodies. 
In male fat bodies, DSXM  is present and binds to the dsxA site, and because the 
DSXM protein has a bulkier male-specific carboxy-terminal domain it can sterically 
hinder activation by bZIP protein. Alternatively, bZIP may be inactivated by DSXM , 
this is not shown in Figure 3.12. DSXF  is not present and therefore cannot bind 
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Figure 3.12 
Model for transcriptional regulation by o-r. 
Top 
Activation in female fat bodies resulting from synergy among the DSXE,  bZJPa and R 
proteins. Curved arrows indicate activation, and the arc between bZIPa and R 
repesents positive cooperativity. These three proteins are shown bound to their 
cognate sites on o-r DNA (solid lines). The AEF-1 repressor is shown unbound, 
excluded from its DNA site by DSX. Broken lines represent DNA between o-r, and 
the promoter (right angle arrow). 
Middle 
Repression in male fat bodies resulting from DSXM .  DSXM is shown bound to DNA, 
excluding the other two proteins from binding. 
Bottom 
Inactivation in ovaries and tissue specificity. The absence of dsx proteins allows 
AEF-1 to bind, excluding activators from the bZIP site. The bZIPa and bZIPb 
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refi 
cooperatively with the bZIP activator. The elimination of bZIP activation removes 
synergy with an activator at the refi site and will not yield gene expression in the 
male fat body. It is thought that AEF-1 is unlikely to repress in male fat bodies 
through o-r because of steric hindrance by DSXM. 
In ovaries it is proposed that due to the absence of DSX proteins, the AEF-1 
repressor binds and excludes activators from the bZIP site. The bZIPa and bZIPb 
(proposed tissue-specific bZIP in the ovary) activate from the bzip 1 site but have 
different tissue distributions. 
Some points to note about these experiments and the subsequent model 
Enhancers are expected, by definition (Serfling et al., 1985), to activate transcription 
independent of orientation. In the experiments using o-r (An and Wensink, 1995a, An 
and Wensink, 1995b) the constructs do not appear to have been tested in the reverse 
orientation. 
There also seems to be some degree of confusion about the role of bZIP activators in 
the ovary. The model states that the AEF-1 repressor binds and excludes activators 
from the bZIP site, and that the bZIPa and bZIPb activate from the bzip 1 site but 
have different tissue distributions, suggesting that bZIPb activates in ovaries. If the 
AEF- 1 repressor excludes activators from the bZIP site in ovaries, then surely a 
bZIPb protein cannot activate from the bzipl site? If bZIP proteins really are 
activating expression in the ovary from bzipl, they do not appear to be activating yp 
expression because the expression is not in the correct cells, the yps are expressed in 
the follicle cells surrounding the oocyte during stages 8-1Ob of oogenesis (see Chapter 
4). The ovarian enhancers OE1 and 0E2 have been found to be necessary for yp 
expression in the ovary (Logan et al., 1985 and Logan and Wensink, 1990). 
Another paper has been published recently, Li and Baker (1998), describing the role 
of the hermaphrodite (her) gene and dsx in the regulation of the yps. It is proposed 
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that they control the expression of the yp genes in the fat body by two separate 
pathways for the activation of the yps. One pathway is the non-sex-specific 
activation of the yps, which is HER-dependent, DSXFindependent  and inhibited by 
DSXM. The other pathway is the female-specific activation of the yps, which is 
DSXF dependent. The combination of these effects, in wild type females, results in 
both HER and DSXF  contributing independently to produce high level expression of 
the yps. 
In wild type males, DSXM  inhibits yp expression, which can override the activation 
function of HER. HER is a zinc finger protein and is thought to regulate the yps 
directly. The 125bp FBE of ypi and yp2 (position -196 to -322) was not found to be 
sufficient to confer her responsiveness, and the major her responsive element is 
located outside of FBE. The her responsive region, termed HRR, is located between 
nucleotide positions -322 to -1225 in the intergenic region of ypi and yp2. dsx does 
not confer the fat body-specific expression of the yps, because in dsx mutant flies of 
both sexes, the expression of yp-reporter genes is still restricted to fat body cells. 
HER is also not considered to be necessary for fat body-specific expression of the 
yps because loss of her does not affect fat body-specific expression of a transgene, 
and the FBE-reporter construct can confer fat body-specific expression without the 
HRR present. An unknown fat body-specific factor, termed FBF, binding possibly 
to the bZJP site in the FBE is thought to confer tissue-specificity to the fat body 
only. The HRR is necessary for her function but is not thought to be sufficient for yp 
expression, it is deemed likely that the FBF is also necessary for HER to direct the 
expression of yps. In addition to her and dsx, the intersex (ix) gene also acts in the dsx 
branch of the sex determination pathway. It has been observed that ix is also required 
for the transcriptional activation of the yp genes in females, but is not required for 
their repression in males. Genetic studies indicate that ix interacts with her and with 
dsx in regulating the yps in females (Baker, unpublished data). It is thought that Lt 
may participate both in the HER-dependent non-sex-specific activation pathway and 
in the DSX'-dependent female-specific activation pathway. It is postulated that a 
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candidate DNA site in the EBE through which IX might function is the "refi" site, 
shown to synergistically function with the DSX binding site, dsxA (An and Wensinic, 
1995b). 
It should also be mentioned that other sexual phenotypes were found in this study to 
be created by strong interaction between HER and DSXF,  for example the number 
and morphology of the last transverse row of bristles (LTRB) of the basitarsus 
(LTRB form sex combs in males) and the degree of pigmentation of tergites 5 and 6 
(T5 and T6). The authors also acknowledge that the her mutants used in these 
studies have a low level of activity, to rescue lethality, and this might complicate the 
results observed, as different activations may have different thresholds. 
Considering now the results for the FBE3 and its subfragments, the most intriguing 
observation is the loss of sex-specificity in fat body expression. All previous studies 
to identify tissue-specific enhancers associated with the yp genes found that the sex-
and tissue-specificity of expression were never separated. Another interesting point 
about the sex-specificity is the role of DSX protein, the 177bp fragment that showed 
male and female fat body expression in the germline transformation experiments was 
also found to bind specifically to DSX binding domain protein in gel shift assays. It 
is considered that the action of DSX binding activates expression in females and 
represses expression in males, but this does not appear to be the case in this system. 
These two observations suggest that regulation of the yp3 gene may not occur in 
exactly the same way as for ypl and yp2; the factors involved may be the same but 
the details of the mechanism or organisation of the interacting binding sites could be 
different. 
There was a possibility that the isolation of the 1 77bp fragment could have disrupted 
any binding sites located at the 3' end (around -527 position), there could have been a 
dsx binding site responsible for conferring sex-specificity to female expression only, 
for example. To resolve this situation, the 177bp fragment was extended to 190bp 
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and 206bp. However, transformation of these constructs into flies showed that they 
exhibited the same expression patterns as the 1 77bp fragment; reporter gene 
expression was either found in both male and female fat bodies or in neither sex. The 
246bp fragment adjacent to the 177bp fragment was not found to bind DSX binding 
domain protein in vitro, and it seems unlikely that further extension of the 206bp 
fragment will provide extra dsx sites to confer sex-specificity. It seems likely that for 
yp3 another factor, in addition to DSX, is required for sex-specificity, and that its 
binding site is present in the 246bp subfragment of FBE3, but not between 
nucleotides -528 and -498. 
It was also considered that extension of the 177bp fragment might have eliminated 
the occurrence of transformed fly lines that did not give expression in either sex. The 
observed expression patterns found with the 177bp fragment could be explained by 
an activator and/or repressor binding site being lost in the isolation of the fragment. 
Computer searches revealed putative AEF-1 and C/EBP (bZIP) binding sites located 
in the 29bp sequence extended on the 1 77bp fragment to create the 206bp fragment, 
it seemed possible that this sequence could contain the missing sites needed to 
restore the correct yp expression pattern in every line transformed. However, 
addition of these putative binding sites did not appear to have any affect upon 
reporter gene expression, and there were still lines that did not show any expression 
in either sex. 
The result that expression is not switched on in every line seems likely to be a 
position effect, and depends upon where in the Drosophila genome the P-element 
construct has inserted. If the 1 77bp fragment alone is not sufficient to direct fat body 
expression due a missing activator site, certain locations of insertion in the genome 
may place the fragment near an activator sequence, resulting in some lines being 
capable of expression. It may be that the action of the external activator, in the lines 
that give expression, does not provide sex-specificity resulting in expression in the 
fat body of both sexes. The missing activator site could bind a sex-specific activator 
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or one that interacts with DSXF  to give activation in females only. Conversely, if the 
177bp fragment alone is sufficient to direct fat body expression, but not sex-
specifically, the loss of expression in some lines could be due to location of the P-
element in the genoine so that the fragment is affected by silencers or repressors (for 
a review of silencers, see Ogbourne and Antalis, 1998). Silencers have been defined as 
sequence elements which are capable of repressing promoter activity in an 
orientation- and position-independent fashion, in the context of a native or a 
heterologous promoter (Brand et al., 1985). This theory does not explain the loss of 
sex-specificity, unless the silencing effect happens in conjunction with there being a 
sex-specific site missing from the 177bp fragment. 
Considering the model proposed for ypl12 regulation, it may be possible that a 
homologue of the refl site, binding the unknown activator R, is missing from the 
1 77bp fragment and is located in the 246bp fragment. If this is the case, in the 
regulation of yp3 the activator R would need to be capable of conferring sex-specific 
expression, possibly by interaction with DSXF  or by itself, to give expression in 
female fat bodies only. 
If the regulation of yp3 is different to that of ypl and yp2, it could be that sex-
specificity is conferred by the interaction of /w-, dsx and ix and the HER and/or IX 
binding sites are missing from the 177bp fragment. 
It is interesting to note that in Musca and Calliphora, upstream yp sequences were 
also unable to confer sex-specific reporter gene expression in the fat body, and 
expression was observed in the fat body cells of both males and females (Tortiglione 
and Bownes, 1997). The Musca upstream fragment was also found to be capable of 
binding DSX protein in vitro, but this was not sufficient to confer sex-specificity of 
expression in vivo. These results indicated that the regulation of the yps inMusca and 
Calliphora is different to that of yp] and yp2 due to divergence between the species, 
and it was suggested that hormonal controls might be used to achieve the sex-specific 
expression of the yp genes in Musca and Calliphora. The results obtained in this 
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project for yp3 fat body regulation are very similar to those seen for the regulation of 
the yps in Musca and Calliphora. It appears that yp regulation has diverged between 
yp]Iyp2 and yp3, but conserved between yp3 and the yps of Musca and Calliphora. 
The results obtained for yp3 also suggested that DmC/EBP, encoded by the sibo gene 
is not the bZIP protein required for activation of the yp genes. The levels of YP 
protein in haemolymph, a measure of YPs produced by the fat body, showed no 
significant difference in trans-heterozygous sibo mutants compared to their 
heterozygous siblings. It would be expected that the loss of an activator of the yps 
would result in less transcriptional activation and thus less YP protein expression, 
but this effect was not observed. This result is consistent with the findings that the 
DmC/EBP transcript was undetectable in adult fat bodies (Rorth and Montell, 1992), 
which indicates that the DmC/EBP protein is not expressed in the right cells to be a 
fat body-specific gene activator. 
Future work on the regulation of yp3 is needed to determine what region of the 246bp 
fragment of the FBE3 is capable of restoring the sex-specificity to female fat bodies 
only. It would then be interesting to find out which protein(s) bind to this site to 
direct sex-specificity. The DSX proteins could be used in footprinting assays to 
locate their actual binding site within the 177bp fragment. There are many candidates 
foryp3 regulators: AEF-1, bZIP, HER, IX, whose involvement could be investigated, 
for example by identifing footprints and mutating binding sites for these proteins. 
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CHAPTER 4 
RESULTS 
Regulation of yp3 in the ovary 
4.1 INTRODUCTION 
Experiments to identify enhancers governing yp3 expression revealed a 328bp 
fragment immediately upstream of the yp3 coding sequence was sufficient to confer 
an ovarianyp expression pattern (Ronaldson and Bownes, 1995). The j3-galactosidase 
activity was detected in ovarian follicle cells during stages 8-10 of oogenesis, and was 
termed 0E3. A 150bp PCR fragment was also produced from this region (Figure 
4. 1), and found to bind specifically with components of ovarian nuclear extracts in 
gel retardation assays (Ronaldson and Bownes, unpublished data). The 150bp 
fragment was created to exclude the yp3 TATA and CAAT-box promoter elements, 
the reason for this was to exclude the binding of their associated proteins in ovarian 
nuclear extracts, and thus only show gel shifts with potential DNA binding proteins 
involved in ovarian yp3 regulation. This 150bp fragment was also isolated because it 
contained four sites of conserved sequence, revealed by computer similarity searches 
between OE1, 0E2 and 0E3. These sites include a consensus sequence, reported by 
Tortiglione and Bownes (1997), which is present in OE1 and 0E3, but is also 
conserved between Musca and Calliphora yp upstream regions, shown in Figure 4.2. 
The presence of this sequence motif in all three species suggests a potential 
functional role as a binding site for ovarian-specific factors. 
In this project the lSObp fragment was investigated further to determine if it was 
sufficient to direct yp ovarian expression, and possible candidates for trans-acting 
factors required to regulate the correct yp3 expression pattern in the ovaries were also 
investigated. 
4.2 YP EXPRESSION IN THE OVARY 
Original investigations into the yp expression pattern in the ovary utilised a crude in 
situ hybridisation method, using a 311-labelled probe, that only showed roughly when 
expression was occurring and that the yps were expressed in the follicle cells 
(Brennan etal., 1982). To obtain a clear picture of the yp gene expression pattern, in 
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Figure 4.1 
A diagram of the Drosophila yp3 gene illustrating the location of the 150bp 
subfragment of 0E3 used in reporter gene assays. It can also be seen that the 150bp 
fragment does not contain the yp3 TATA and CAAT-box promoter elements that are 
present in the 328bp 0E3 fragment. 
The positions of the identified enhancer regions, 0E3 and FBE3, are also shown. All 
nucleotide positions are given relative to the yp3 transcription start site. 
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Figure 4.2 
Sequence similarities between Drosophila ovarian enhancers OE1 and 0E3 and 
sequences from Musca (Mupro8) and Calliphora (Ceprol) constructs, located 5' of 
Musca Mdypa gene and Calliphora CeypB gene respectively (Tortiglione and 
Bownes, 1997). 
The vertical lines indicate nucleotide identities. Nucleotide positions of OE  and 0E3 
are given relative to the transcription start sites of ypi and yp3 respectively. 
Calliphora and Musca nucleotide positions are relative to the CeypB and Mdypa 
genes respectively. 
Underneath the sequences, percentage similarities relative to the OE1 sequence are 
shown. 
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situ hybridisations to whole mount Drosophila ovaries were carried out using the yp 
genes as digoxygenin DNA probes. This method allows much more precise 
observation of the cells expressing theyp genes. 
The yp clones detailed in section 2.2 were used to generate yp fragments for the 
synthesis of digoxygenin DNA probes. The following probes were used: an 800bp 
ypi probe (isolated by a restriction digest with BarnHI), a 541bp yp2 probe (isolated 
by a restriction digest with HindIII and BglII) and a 1 500bp yp3 probe (isolated by a 
restriction digest with HindIII and BgllI). The yp probes were used for in situ 
hybridisation to whole mount Drosophila ovaries, these methods are detailed in 
section 2.5.7. 
The results show that yp gene expression is switched on at stage 8 of oogenesis in the 
follicle cells surrounding the egg chamber, and their expression continues until stage 
lOb (Figure 4.3). During stages 8-10 the oocyte undergoes rapid gowth as a 
consequence of the uptake of yolk proteins which are synthesised in the fat body 
and the follicle cells. At stage 8 the follicle cells form a monolayer surrounding the 
entire egg chamber. During stage 9 anterior follicle cells, which overlay the nurse cells, 
elongate and migrate posteriorly, by stage lOa the oocyte is covered by a sheet of 
thick columnar follicle cells and the nurse cells have very few follicle cells associated 
with them. This follicle cell migration can be observed in the pattern of yp gene 
expression, which moves down the egg chamber as the follicle cells expressing them 
migrate. This expression pattern was found to be the same for all threeyp genes. 
The follicle cells initially covering the nurse cells, which are programmed to migrate 
later to cover the oocyte, have the yp genes activated in advance of being adjacent to 
the oocyte. This means that the signal to activate the yp gene expression in the follicle 
cells does not originate in the oocyte. The yp gene expression is also not in all the 
follicle cells, there is a clear gap in the expression pattern in the anterior follicle cells 
when expression is first observed. This shows a subdivision in the follicle cells that 
was not previously described in relation to yp gene expression in the ovary. 
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Figure 4.3 
In situ hybridisation of a ypl DNA probe to whole mount Drosophila ovaries. 
Expression occurs in the ovary between stages 8 and lOb, specifically in the follicle 
cells surrounding the egg chamber, which migrate posteriorly to cover the oocyte 
during stage 9. 
All three yp genes, ypi, yp2 and yp3, gave the same expression pattern. 
U 
In summary, the three yp genes, ypl, yp2 and yp3, are all expressed in the ovary 
between stages 8 and lOb. Specifically, the yp expression occurs in the follicle cells 
surrounding the egg chamber, which migrate posteriorly to cover the oocyte during 
stage 9. These results are also useful as a comparison for reporter gene expression 
patterns for constructs being tested for ovarian yp3 enhancer capabilities. 
4.3 ANALYSIS OF A CIS-ACTING FRAGMENT REQUIRED FOR OVARY-
SPECIFIC EXPRESSION 
4.3.1 Construction and Analysis of the Reporter Constructs 
The lSObp subfragment of 0E3, shown in Figure 4.1, was tested to determine if it 
was sufficient to direct lacZ reporter gene expression, in the correct pattern for yp 
ovarian expression, when transformed into Drosophila. 
The 328bp 0E3 fragment cloned in the pCaSpeR-AUG-3gal vector, named yp3/5, 
was used as a template to synthesise a 1 5Obp PCR product, which spanned 
nucleotides -197 to -47. The 150bp fragment lacked yp3 promoter elements and 
therefore required cloning into the P-element transformation vector pERI, which 
contains a heterologous promoter, hsp7O. The PCR product was purified and cloned 
into pERI cut with EcoRI, blunt ended and CLAP treated (to prevent vector 
religation). This allowed the lSObp fragment to be cloned in both forward and reverse 
orientations, which were verified by sequencing. The sequence of the PCR product 
was also checked to confirm that no mutations had been introduced by the PCR 
reaction. Construct 0 was the 1 5Obp PCR fragment in the forward orientation and 
construct H two copies in the reverse orientation, diagrams of these reporter 
constructs are shown in Figure 4.4. 
Constructs 0 and H were introduced into the Drosophila germline using standard 
transformation techniques (Rubin and Spradling, 1982), detailed in section 2.5.3.1. At 
least three independently transformed lines were assayed for each construct tested. 
Ovaries were dissected from female transformants and used for histochemical staining 
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Figure 4.4 
A diagram of the yp3 constructs tested for transcription enhancer elements regulating 
yp3 ovarian expression. At the top is a schematic diagram of the yp3 gene showing the 
328bp 0E3 region found to be capable of directing ovary-specific yp3 expression. 
The hatched boxes represent introns within the yp3 coding sequence. Transcripts and 
their direction of transcription are represented by arrows. The sizes (in bp) of the 
yp3 fragments used in reporter constructs are indicated below the constructs, the 
nucleotide positions in relation to the yp3 transcription start site and the orientation 
of the fragments are indicated above. 
AUG 





H 	 sp7O-lacZ 
to determine the ability of each construct to direct ovarian yp3 regulation. Reporter 
gene expression was detected by blue colouration produced by 3-galactosidase 
activity and the effects of each construct were analysed. To compare position effects 
between constructs all body parts were used for staining (discussed in section 1.4). 
Because the transformed constructs were not used for quantitative assays, merely the 
presence or absence of 3-galactosidase activity, the transformed lines were not 
analysed for the copy number of constructs they contained. If the transformed lines 
were used for quantitative assays in the future, the construct copy numbers would be 
analysed and single copy inserts used. 
The 328bp 0E3 was found to direct reporter gene expression in ovarian follicle cells 
during stages 8 to lOb, this fragment contained yp3 promoter sequence and was 
transformed using the pCaSpeR-AUG-[3gal vector (Ronaldson and Bownes, 1995). 
This meant that the 328bp 0E3 fragment was tested in the forward orientation only, 
and its ability to act as an enhancer in the reverse orientation is unknown. 
Constructs G and H, containing the 1 SObp fragment in forward and reverse 
orientations, were also found to be capable of directing reporter gene expression in 
ovarian follicle cells during stages 8 to lob, these results are shown in Figure 4.5. 
The majority of transformed Drosophila lines containing constructs G and H showed 
reporter gene expression in the yp expression pattern, however, a few lines did not 
show any staining patterns in the ovary and one line showed a modified expression 
pattern (Figure 4.6). In this line the expression pattern did not cover the entire 
oocyte; there is expression in the follicle cells around the anterior and posterior of the 
oocyte, but there is a band of staining missing around the centre of the oocyte. 
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Figure 4.5 
Photographs illustrating the 3-galactosidase activity observed in Drosophila ovaries 
transformed with constructs G and H containing 150bp of yp3 upstream sequence. 
Reporter gene expression, and thus 3-ga1actosidase activity, is shown when tissues 
are stained with X-Gal and produces a blue colouration. 
X-Gal stained ovaries (A) of flies transformed with constructs G and H, showing 
reporter gene activity. The lines used for these examples were (51A)17-1 (top) and 
(51B)6-1 (bottom). 
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Figure 4.6 
An example of fly line (51 B)45, transformed with construct H, which shows a 
modification of the vp expression pattern in the ovary. 
In this line the X-Gal staining pattern did not cover the entire oocyte, a band of 
staining was missing around the oocyte, this is thought to be due to a chromosomal 
position effect. This area is marked by an arrow. 
*IIt :•• 	 4-4 
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In summary, it appears that the 150bp subfragment of 0E3 is capable of directing 
reporter gene expression in ovarian follicle cells during stages 8 to lob, and may 
contain all necessary sequences to be the enhancer for yp3 expression in the ovary. 
The staining pattern for the 150bp fragment was also identical to the pattern 
observed for the 328bp 0E3 in reporter constructs transformed into flies (Ronaldson 
and Bownes, 1995). 
4.4 INVESTIGATION OF TRANSCRIPTION FACTOR CANDIDATES 
Very little is known about the regulatory mechanisms involved in ovarian yp 
expression and no transcription factors regulating yp expression in ovaries have been 
identified to date. It is possible that the transcription factors identified for the 
regulation ofypl and yp2 in the fat body could also be responsible foryp regulation in 
the ovary. Two of these factors (DSXF  and DSXM)  are products of the doublesex 
gene; the doublesex gene is the final gene in the sex determination pathway and 
encodes both male-specific and female-specific polypeptides, whose synthesis is 
regulated by alternative sex-specific splicing of the primary dsx transcript. The only 
target genes shown to be under direct control of the sex determination hierarchy are 
the yolk protein genes, specifically ypi and yp2 gene expression in the female, fat 
body tissues (Burris et al., 1991). Genetic evidence has indicated that dsx is not 
involved in regulatingyp gene expression in the ovary, and that the expression of the 
yps in the ovary is not under the continuous control of the sex determination 
hierarchy (Bownes et al, 1990). To investigate if dsx is expressed in the ovary, and to 
verify the genetic data, it was decided the ovarian expression pattern of dsx would be 
determined by in situ hybridisation. Other transcription factors regulating ypi and 
yp2 in the fat body include AEF-1 and DmC/EBP (sibo) proteins, and it was decided 
their possible role in regulating yp expression, in the ovary, would be investigated. 
Transcription factors regulating tissue-specific yp gene expression in the ovary are 
expected to be expressed at the same developmental stages and cells as the yps, to be 
capable of performing this function. It was therefore decided that the expression 
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patterns of aef-I and sibo would be determined by in situ hybridisation to investigate 
their potential role in ovarian yp regulation. The aef-1 gene encodes the Adult 
Enhancer Factor- 1 protein, AEF- 1, which is thought to be a transcription factor 
involved in the regulation of fat body expression of the yps and the adh gene. The 
Drosophila homologue of C/EBP (DmC/EBP) is encoded by the slow border cells 
(sibo) gene (Montell et al., 1992). The slbo gene encodes a CCAAT/enhancer-binding 
protein, a basic region-leucine zipper transcription factor, which is a member of the 
bZIP family of proteins. 
DNA probes were labelled with the PCR DIG labelling mix (Boehringer Mannheim) 
to give increased sensitivity compared to the standard DNA digoxygenin probes, the 
methods are detailed in section 2.5.7.1. Initial experiments were performed using 
standard DNA digoxygenin probes but they gave high background staining, these 
problems were resolved by using the PCR labelling method. 
The primers T3 and T7 were used to generate PCR probes for aef-I from the plasmid 
bs035, containing the aef-] cDNA, and also dsx from the plasmid pGEX-KG. The 
dsx probe contained the DSX DNA binding domain encoding sequence common to 
both male- and female-specific transcripts. The primers CEBPRF2 and CEBPRR2 
were used to synthesise a slbo probe by PCR from the plasmid named DmC/EBP. 
These probes were used for in situ hybridisations with whole mount ovaries and the 
results are shown in Figure 4.7. All details of plasmids, primers and methods are 
contained in Chapter 2. 
The aef-] gene is expressed in the nurse cells from stage 8, expression levels increase 
to their maximum at stage 10, and by stage 11 expression is reduced to a low level 
and then ceases (Figure 4.7A). It is therefore, not possible for AEF-1 protein to be 
directing yp expression, in the follicle cells surrounding the oocyte, from its location 
in the nurse cells. 
The sibo gene is expressed in just the border cells, which are initially located at the 
anterior end of the egg chamber. These break free from the follicular monolayer and 
migrate posteriorly between the nurse cells during stage 9, the expression pattern can 
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Figure 4.7 
In situ hybridisations to Drosophila whole mount ovaries to investigate potential 
transcription factors for ovarian,yp regulation. 
The DNA probes used are: 
aef-] gene, encodes AEF-1 protein 
slbo gene, encodes DmC/EBP 
the position of the border cells is marked by an arrow 
dsx gene, encodes the DSX DNA binding domain protein, common to male 
and female DSX proteins 
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be seen during border cell migration in Figure 4.713. From observing this expression 
pattern it seems unlikely that sibo expression in the border cells is capable of 
regulating transcription of the yps in the ovary. 
The in situ hybridisations did not give any staining above background for the dsx 
probe (Figure 4.7C), this indicates that c/sit is not expressed in the ovary and thus is 
not a regulator of ovarian yp expression. This is consistent with previous genetic 
evidence against dsx being a regulator ofyp gene expression in the ovary (Bownes et 
al, 1990). 
In summary, it does not appear that either aef-1, sibo or dsx are expressed in the right 
cells to be able to regulate transcription of the yps in the follicle cells. 
4.5 OTHER EXPERIMENTS 
Attempts were made to mutate the first 4bp (by mismatching nucleotides: purines 
exchanged for pyrimidines, and vice versa) and also to delete the 1 Obp consensus 
sequence located within 0E3 (Figure 4.2) by site-directed mutagenesis, but 
unfortunately these experiments were unsuccessful. The aim was to mutate and 
delete the consensus sequence from the 328bp 0E3 and determine if these mutations 
had any affect upon ovarian reporter gene expression when transformed into flies. 
This would have indicated if the consensus sequence was involved in ovarian yp3 
regulation, and also revealed if it were a potential binding site for a transcription 
factor regulating yp3 expression. These mutated sites could also have been used in gel 
retardation assays with ovarian nuclear extracts to find out if they disrupted the 
specific gel shift previously identified (E. Ronaidson, unpublished data). 
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4.6 SUMMARY AND DISCUSSION 
In situ hybridisation of yp DNA probes to Drosophila whole mount ovaries showed 
that all three yp genes have the same expression pattern; they are expressed in the 
ovary between stages 8 and lOb, specifically in the follicle cells surrounding the egg 
chamber, which migrate posteriorly to cover the oocyte during stage 9. 
The 328bp 0E3 of yp3 was used to create a subfragment of 150bp which was found 
to be capable of directing reporter gene expression in ovarian follicle cells during 
stages 8 to lOb of oogenesis, in both forward and reverse orientations. This suggests 
that the 150bp fragment contains sequences responsible for the tissue-specific 
expression of yp3 in the ovary. 
Investigation of potential transcription factors responsible for the regulation of )q.J 
expression by in situ hybridisation did not reveal any likely candidates. It is expected 
that a regulator of tissue-specific expression in the ovary, i.e. limited to certain 
follicle cells, is required to be expressed in those cells in order to perform regulatory 
functions directly. None of the genes tested, aef-1, slbo and dsx showed expression 
patterns in the follicle cells surrounding the egg chamber and then the oocyte during 
stages 8 to lob. 
Although computer searches have indicated there are regions of similarity between 
OE1, 0E2, 0E3 and Musca and Calliphora yp upstream regions, no transcription 
factors have been identified for the regulation of yp expression in the ovary. It is 
possible that regulation of ovarian yp3 expression is less complicated than for ypl 
and yp2, as yp] and yp2 share enhancers for their expression in the ovary. In the 
1226bp intergenic region of yp] and yp2, two ovarian enhancers (OE1 and 0E2) were 
found to regulate the tissue-specific ovarian expression of ypi and yp2. DEl is 301bp 
in length and is situated 43bp upstream of yp2, 0E2 is 1 O5bp in length and is located 
within the yp2 coding region. OE  directs the timing of ypi and yp2 expression to the 
correct stages of oogenesis and limits expression to the ovarian follicle cells. 0E2 
enhances levels of ovarian ypi transcripts and gives tissue-specificity but cannot 
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regulate the expression to the correct stages of oogenesis (Logan et al., 1989, Logan 
and Wensink, 1990). Therefore, to provide the correct levels and pattern expressions 
of ypi and yp2, both OE 1 and 0E2 are required. For yp3 the 328bp 0E3 and a 1 5Obp 
subfragment appear to be capable of directing reporter gene expression to the correct 
stages and cells in the ovary. 
The majority of transformed Drosophila lines containing the 150bp fragment showed 
reporter gene expression in the yp expression pattern, however, a few lines did not 
show any staining patterns in the ovary and one line showed a modified expression 
pattern. These exceptions to the yp expression pattern could be caused by position 
effects, depending upon where in the Drosophila genome they are located. This is a 
common problem with reporter constructs containing small enhancer elements 
without their native promoter. Some lines showed very faint reporter gene expression 
in the yp pattern, it is also possible that lines appearing not to show expression have 
levels too low to show visible staining with -galactosidase. 
Future experiments to investigate the regulation of yp3 would include the 
identification of the ovarian DNA binding protein(s) involved. The 1 5Obp fragment 
could be used to screen an ovarian expression library to identify the cis-acting factors 
regulatingyp ovarian expression. These factors could be used in DNAseI footprinting 
assays to identify their binding sites within 0E3, and site-directed mutagenesis 
followed by P-element mediated transformation would reveal if these sequences were 
involved in enhancer activity. 
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CHAPTER 5 
RESULTS 
Production of Doublesex Antibodies 
5.1 INTRODUCTION 
The doublesex (dsx) gene is the final gene in the Drosophila somatic sex 
determination pathway and thus regulates the genes responsible for sexual 
differentiation in the fly. The primary transcript of the dsx gene is alternatively 
spliced in males and females to yield sex-specific mRNAs which encode male-
specific and female-specific polypeptides (Burtis and Baker, 1989). The two DSX 
proteins are identical for the first 397 amino acids (aa), but have unique carboxy 
tcrmini of 152aa in males and 30aa in females. The male-specific doublesex 
polypeptide, DSXM  is thought to repress the expression of female-specific genes in 
males, and conversely, the female-specific doublesex polypeptide, DSXF  is thought 
to repress the expression of male-specific genes in females. The N-termini of 397 
amino acids, common to DSXM  and  DSXF,  contains a zinc finger-related DNA 
binding domain (Erdman and Burtis, 1993) and it has been established that the DSX 
proteins can act as DNA binding transcription factors. 
Despite the extensive studies into the developmental consequences of dsx mutations, 
very little is known about the molecular interactions of DSX with its target sexual 
differentiation genes. The only target genes shown to be under direct control of the 
sex determination hierarchy are the yolk protein genes, specifically ypi and yp2 
(Burtis et al., 1991). 
In this project, DSX binding domain protein was found to bind specifically to a 
fragment located upstream of the yp3 gene, which was also found to be involved in 
fat body-specific regulation of yp3 (Chapter 3). The expression of dsx was also 
investigated in Drosophila ovaries, to determine if it was a candidate for a 
transcription factor regulating yp expression in the ovary (Chapter 4). No evidence 
was found by in situ hybridisation for dsx expression in the ovary, and there have 
never been reports of dsx transcripts found in the ovary. Very little is known about 
actual DSX protein expression in Drosophila, the DSXM  and DSXF  proteins have 
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been expressed in bacterial cultures to use in binding assays, but the localisation of 
DSX in tissues has not been reported. 
Antibodies to DSX binding domain protein were made during this project to 
investigate DSX protein expression in male and female fat bodies, considering that 
they are proposed to be regulators of fat body-specific yp expression. It was also 
hoped that the DSX antibodies could finally determine if DSX is produced in the 
ovary. The antibodies could also be used to look at DSX expression and localisation 
throughout development. There are specific questions that could be answered, for 
example, the involvement of dsx in the development of the male foreleg. The male 
foreleg carries the sex comb and the pattern of neuronal axons differs between the 
male and female first legs. Experiments using ectopic expression of a dsx male-
specific eDNA in flies showed that sex comb morphology could be induced in female 
forelegs, and also on the second and third legs of both sexes. This has led to the 
suggestion that DSXM  positively promotes the development of male-specific 
structures of the foreleg (Jursnich and Burtis, 1993). However, dsx null mutants do 
not have a similar phenotype, and dsx mutants constitutively expressing DSXM  do 
not have sex combs on other legs. It is possible that dsx is not normally expressed in 
these cells and high levels of expression may lead to new phenotypes by interactions 
with different combinations of tissue-specific transcription factors. The DSX 
antibodies could be used to identify if DSX is expressed in the male foreleg and the 
foreleg imaginal disc; this would determine if DSXM  is present and therefore capable 
of having a role as a promoter of sex-specific gene activation. 
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5.2 PRODUCTION OF DOUBLESEX DNA BINDING DOMAIN PROTEIN 
A pGEX T7 expression vector containing the N-tçrminal DNA binding domain 
common to both DSXM  and DSXF  proteins (amino acids 1-397) was used to express 
this domain as a glutathione-S-transferase (GST) fusion protein in BL21 (DE3) cells. 
The vector, named pGEX-KG, was a gift from K. Burtis (University of California). 
The GST-DSX fusion protein was estimated to have an approximate molecular 
weight of 37.5kDa, this was calculated by adding together 26kDa for the GST 
protein and 11.5kDa for the DSX DNA binding domain protein (calculated from 
average amino acid molecular weight values). The method for DSX DNA binding 
domain protein expression and purification was adapted from Erdman and Burtis 
(1993), and is detailed in section 2.5.4. The GST-DSX was purified from the 
bacterial cell extract using glutathione-agarose beads to bind the GST-DSX, which 
was then eluted from the beads in Z-50 buffer. Samples were taken during the 
purification stages and analysed by SDS-PAGE, an example of this is shown in 
Figure 5.1. The GST-DSX eluted from the glutathione-agarose beads migrates at 
approximately 40kDa, shown in lanes 5 and 6, and it can be seen that the first elution 
releases more protein from the beads than subsequent elutions. It is also clear that the 
purification procedure has successfully removed other bacterial cell proteins from the 
sample. The Z-50 buffer was used because it contained protease inhibitors which 
minimise degradation of the protein sample, however, Z-50 buffer is unsuitable for 
injection into animals for antibody production. Therefore, the GST-DSX was 
produced in Z-50 buffer, checked on SDS-PAGE and then dialysed into phosphate 
buffered saline (PBS) which can be used for injection into animals. The protein 
concentration of the sample was determined by the Bradford assay and the sample 
was concentrated accordingly, using an Ultrafree-4 centrifugal filter unit (Millipore), 
to give a protein concentration of approximately 1 jtg/fl. A sample of the protein was 
checked again by SDS-PAGE prior to injection into mice, because the dialysis into 
PBS can result in slight degradation of the sample in the absence of protease 
inhibitors. 
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Figure 5.1 
The expression and purification of DSX DNA binding domain protein. 
The DSX DNA binding domain protein was expressed as a glutathione-S-transferase 
(GST) fusion protein in BL21 (DE3) cells. Samples were taken from bacterial cell 
extracts during the expression and purification procedure, separated by SDS-PAGE 
and stained with ISS-ProBlue. 
Lane 1: 	pre-stained protein molecular weight markers (BioRad), the sizes are 
shown in kDa 
Lane 2: 	bacterial cell extract taken from lysed cells 
Lane 3: bacterial cell extract after incubation with glutathione-agarose beads 
Lane 4: 	wash solution from the glutathione-agarose beads 
Lane 5: first elution of GST-DSX from the glutathione-agarose beads 
Lane 6: 	second elution of GST-DSX from the glutathione-agarose beads 











5.3 ANTIBODY PRODUCTION 
The research adjuvant TiterMax®Gold  was used to provoke an immune response to 
the antigen (GST-DSX) in mice, the antigen was mixed with adjuvant at a 50:50 ratio, 
and the two components were mixed by vortexing until an emulsion formed. Five 
MF1 mice were anaesthetised with Halothane and each bled from the eye (10 drops 
of blood) to give a sample of pre-immune serum. The mice were then injected with 
100111 of a stable emulsion of antigen-TiterMax ®Gold, which contained SOjil of 
antigen (lj.tg/.tl protein) and 50jil TiterMax ®Gold. The injections were given 
subcutaneously at the base of the tail. Primary bleeds were taken after 4 weeks by 
bleeding from the eye and a boost injection of antigen (50111 of lwg/.tl protein) in PBS 
was given after 6 weeks. The GST-DSX protein used for the boost injection was 
prepared freshly and checked by running a sample on SDS-PAGE before injection 
into the mice. Secondary bleeds were taken after a further 3 weeks and the mice were 
bled out after another 16 weeks. All the mouse handling and serum preparation was 
performed by Kay Samuel (ICAPB, University of Edinburgh). 
5.4 ANTIBODY RESULTS 
Initially the five DSX antibody samples were tested with a BL21 (DE3) cell extract 
(without transformed construct), to look at their background cross-reactivity, and 
also with a sample of GST-DSX to check their reactivity. The protein samples to be 
tested were run on SDS-PAGE, along with pre-stained markers (BioRad), and the gel 
was used for Western blotting (detailed in section 2.5.5.3). The filter was stained 
with Ponceau S to check the transfer and then used for immunostaining. The HRP 
method for antibody staining was used and a sample of these results is shown in 
Figure 5.2. Lane 1 contains pre-stained protein markers (BioRad), lane 2 is a BL21 
(DE3) cell extract and lane 3 is a sample of GST-DSX. The strong staining observed 
with GST-DSX in lane 3 shows that the antibody has good recognition and binding 
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Figure 5.2 
Western blot analysis of BL21 (DE3) cell extracts using DSX antibodies (number 8), 
and the HRP method of immunodetection. 
Lane 1: 	pre-stained protein molecular weight markers (BioRad), the sizes are 
shown in kDa 
Lane 2: 	bacterial cell extract taken from BL21 (DE3) cells without the pGEX-KG 
plasmid, i.e. not expressing GST-DSX protein 
Lane 3: 	purified GST-DSX protein. 
The position of the 40kDa GST-DSX protein is marked with an arrow. 
Marker size 












with its antigen. The immunostaining also shows up degradation of the GST-DSX 
protein, as smaller bands appear under the main GST-DSX migrating at -4OkDa. On 
SDS-PAGE, stained with ISS Pro-Blue, the same GST-DSX sample appeared to 
have a strong band of intact GST-DSX with very slight degradation visible on the gel. 
It therefore seems that the immunostaining detects degradation products of GST-
DSX more strongly than ISS Pro-Blue staining on a polyacrylamide gel. All of the 
GST-DSX antibodies, from all 5 mice, gave iinmunostaining with a GST-DSX 
protein sample. Against the BL21 (DE3) cell extract all five antibody samples 
brought up a large sized protein on the filter, this can be seen faintly in lane 2 of 
Figure 5.2. Three of the GST-DSX antibody samples also showed a reaction with 
another smaller protein in the BL21 (DE3) cell extract. The antibody used in Figure 
5.2, named number 8, gave strong staining with GST-DSX protein and low 
background with the BL21 (DE3) cell extract, and was therefore used in subsequent 
immunostaining experiments. 
The GST-DSX antibody (number 8) was then used for immunostaining of Western 
Not filters containing Drosophila tissue samples. Adult Drosophila were aged to 3 
days, to ensure oogenesis was proceeding, before being dissected and the proteins 
separated by SDS-PAGE. The tissues used were: ovaries, testes, male carcass and 
female carcass (the carcass contains the fat body cells which cannot be isolated easily 
from the cuticle), a mixture of pupal stages were also used as a control because they 
are expected to contain both male and female forms of DSX protein. Initially, the 
HRP method of immunodectection was performed, but this did not produce any 
bands of staining on the filter even if high levels of primary (GST-DSX) antibody 
were used. 
The next procedure used was the ECL method for immunostaining, which gives much 
greater sensitivity than the HRP method. The ECL method produces a 
chemiluminescant reaction which is detected by autoradiography and because it is 
also a very sensitive method high backgrounds are sometimes seen. Western filters 
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were produced containing proteins from pupae, ovaries, testes, male carcass and 
female carcass, these were used for ECL immunodetection using the GST-DSX 
antibody (number 8). Generally, the DSX antibodies were diluted 1:1000 in PBS-T, 
and the secondary anti-mouse HRP conjugated antibodies were diluted 1:5000 in 
PBS-T. An example of these results is shown in Figure 5.3. The strongest bands seen 
are in the male carcass and female carcass, lanes 3 and 4, these correspond to an 
approximate size of 40kDa. Another larger protein band comes up in the female 
carcass lane that is approximately 70-75kDa in size. No immunostaining is detected 
in testes or ovaries. 
Predictions of DSXM  and  DSXF  sizes calculated from the amino acid sequences were 
58.5kDa (DSXM)  and 45.8kDa (DSXF).  The DSX polypeptides were then 
overexpressed in E. coli from pT7-7 constructs containing DSXM  and  DSXF  encoding 
cDNAs, to give the DSX polypeptides as fusion proteins containing 10 additional 
amino acids. The migration of the male and female proteins on SDS-PAGE indicated 
molecular weights of 67 kDa for the female fusion protein and 52kDa for the male 
fusion protein (Burtis et al., 1991). Apparently, results obtained from pT7-7 
constructs containing DSXM  and  DSXF  encoding cDNA5, to give the DSX 
polypeptides without any additional amino acids fused to them, gave identical 
results. From these results it seems that the DSXM  and DSXF  polypeptides are 
significantly larger than initially predicted. 
The identity of the 40kDa protein seen in both males and females (Figure 5.3) is 
therefore unknown. The larger protein band observed in the female carcass lane could 
be DSXF,  but more investigation of this would need to be made before thawing 
conclusions. 
To check that the 40kDa protein was not a product of degradation and to verify its 
size, the filter was reprobed with YP antibodies. The YPs are 47kDa (YP1), 46kDa 
(YP2) and 45kDa (YP3), and are produced in females only. These results are shown 
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Figure 5.3 
Western blot analysis of Drosophila tissue samples using DSX antibodies and the 
ECL method of immunodetection. 
Lane 1: pupae 
Lane 2: male carcass 
Lane 3: female carcass 
Lane 4: testes 
Lane 5: ovaries 
The sizes (in kDa) and locations of protein molecular weight markers are indicated. 
The arrow indicates the -'4OkDa protein in the male and female carcass samples, and 









in Figure 5.4, and the YPs can be seen clearly in the female carcass and ovary lanes. 
There appears to be slight degradation in the ovary sample, but not in the female 
carcass lane, this shows that there is plenty of undegraded protein in the ovary 
sample. This indicates that the lack of a signal in the ovary with DSX antibodies is 
not caused because the sample is degraded, but because DSX protein is not present in 
the ovary. Since the female carcass protein does not appear to be degraded, the 
40kDa protein showing immunostaining with the DSX antibodies is not likely to be a 
degradation product. It can also be seen that the YPs are larger in size compared to 
the estimated 40kDa size protein, this estimate is therefore, a reasonable one when 
compared to the YPs. 
It appears that despite the GST-DSX antibodies giving strong immunostaining to 
GST-DSX protein, the situation is more complex when the antibody is used with 
Drosophila tissues. A 40kDa protein is recognised by the DSX antibodies in males 
and females, and it is not known at this stage if this protein is a form of DSX or a 
protein cross-reacting with the antibody. It is possible that the DSX antibodies could 
cross-react with zinc-finger proteins other than DSX, if they are present in the 
tissues sampled. 
5.5 SUMMARY AND DISCUSSION 
DSX DNA binding protein was produced in E. coli BL21 (DE3) cells as a 
glutathione-S-transferase fusion protein, and then purified to give a sample containing 
only GST-DSX protein. This GST-DSX protein was used as an antigen to raise 
antibodies in mice. The resulting DSX antibodies were initially tested against a GST-
DSX sample and were found to have good recognition and binding with their antigen. 
One of the DSX antibody samples, referred to as number 8, gave strong 
immunostaining with GST-DSX protein and low background with a BL21 (DE3) cell 
extract, this antibody was used for subsequent experiments. When the DSX 
antibodies were used for Western blot analysis of Drosophila tissue samples, an 
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Figure 5.4 
Western blot analysis of Drosophila tissue samples using YP antibodies and the ECL 
method of immunodetection. 
Lane 1: 	pre-stained protein molecular weight markers (BioRad), the sizes are 
shown in kDa 
Lane 2: pupae 
Lane 3: male carcass 
Lane 4: female carcass 
Lane 5: testes 
Lane 6: ovaries 
The positions of the 45, 46 and 47kDa yolk proteins (YPs) in the female carcass and 
ovary samples are indicated by an arrow. 
- YPs 
approximately 40kDa protein in the male and female carcass samples gave the 
strongest signal. Another larger protein of approximately 70-75kDa gave a weaker 
signal in the female carcass sample. No immunostaining was detected in testes or 
ovaries. 
These results show that the DSX antibodies react strongly to a non sex-specific 
protein of an approximate molecular weight of 40kDa. The identity of the 40kDa 
protein is unknown, the protein might be a form of DSX or a protein cross-reacting 
with the antibody. However, no non sex-specific dsx transcripts have been reported, 
but as very little is known about DSX proteins actually produced in vivo, the 
possibility that there non sex-specific DSX proteins cannot be ruled out. 
Experiments to investigate the potential role of the 40kDa protein could include the 
analysis of dsx mutants. Tissue samples from dsx mutants could be used in Western 
blot experiments to determine if the 40kDa protein is a form of DSX protein. If the 
40 kDa protein is still present in dsx mutants, it is unlikely to be a DSX protein. 
Analysis of the Drosophila tissue samples using "(P antibodies showed that the 
samples were not degraded, and therefore, the 40kDa protein is not a degradation 
product of DSX. The 40kDa protein could be cross-reacting to the DSX antibodies, 
possibly because it contains a similar protein motif as the DSX DNA binding 
domain, for example, a zinc finger binding domain. 
Despite the DSX antibodies giving strong staining with GST-DSX, their affinity for 
DSXM (67kDa) and DSXF  (52kDa) does not appear to be so strong. There are no 
obvious reactions between proteins of these sizes and the DSX antibodies in the 
Western blots analysed so far. The large protein band observed in the female carcass 
lane could be DSXF,  but the size for this protein was estimated to be 70-75kDa, 
compared to 52kDa for DSXF.  Therefore, more accurate estimations of the size of 
this protein need to be made in future experiments. It may be neccessary to affinity 
purify the DSX antibodies to improve their specificity in immunodetection studies. 
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CHAPTER 6 
Final Discussion 
6.1 THE REGULATION OF YP3 EXPRESSION IN THE FAT BODY 
A 419bp DNA fragment, termed FBE3, located 5' of the transcription start site of 
Drosophila yp3, was previously found to direct lacZ expression, in the fat body of 
females, but not males (Ronaidson and Bownes, 1995). This fragment was 
investigated with the aim of identifying trans-acting factors binding to the FBE3 and 
localising the enhancer properties to smaller fragments within the 419bp FBE3. 
Various subfragments of the FBE3 were tested for their effects on lacZ reporter gene 
expression in vivo by P-element-mediated germ line transformation, and assaying for 
13-galactosidase activity by histological staining. Using this technique, a 177bp 
fragment was identified that was capable of directing tissue-specific expression in the 
fat body. However, this fragment was not sufficient to confer the sex-specificity of 
expression to females only, and the reporter gene was expressed in the fat body cells 
of both males and females. It was noted that the 1 77bp fragment only gave this 
expression pattern in 60% of transformed lines, and consequently this result is 
thought to be due to chromosomal position effects. The expression patterns observed 
from the 1 77bp fragment could be explained by an activator and/or repressor binding 
site being lost in the isolation of the fragment, and this being supplied externally as a 
position effect, depending upon where in the Drosophila genome the construct had 
inserted, resulting in lacZ expression in some lines and not others. The 1 77bp 
fragment was used in gel retardation assays and was found to bind specifically to 
DSX protein in vitro. However, this binding does not appear to be sufficient in vivo 
for conferring the sex-specificity of reporter gene expression. These results for fat 
body regulation of yp3 are similar to observations made for the regulation of the yps 
in Musca and Calliphora, where yp enhancer fragments directed reporter gene 
expression in male and female fat bodies despite binding to DSX in vitro (Tortiglione 
and Bownes, 1997). This is in contrast to the results obtained for the FBE of ypi and 
yp2, where the sex- and tissue-specificity of expression were never separated, 
believed to be due to the trans-acting factors having overlapping binding sites within 
the FBE. These results suggest that regulation of the yp3 gene, and also the yps in 
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Musca and Calliphora, may not occur in exactly the same way as for yp] and yp2; 
the factors involved may be the same, but the details of the mechanism or 
organisation of the interacting binding sites could be different. 
Analysis of sibo mutants suggested that DmC/EBP protein is not involved in the 
regulation of the yp genes in Drosophila. The levels of YP protein in the 
haemolymph were not significantly different between homozygous s/ho mutants and 
their heterozygous siblings. The levels of YP protein in the haemolymph provide a 
measure of the YPs produced by the fat body. From these results it seems very 
unlikely that DmC/EBP functions as an activator of yp gene expression in the fat 
body. 
6.2 THE REGULATION OF YP3 EXPRESSION IN THE OVARY 
The exact expression pattern of the yolk protein genes in the ovary was determined 
by in situ hybridisation. These experiments showed that all three yp genes have the 
same expression pattern; they are expressed in the ovarian follicle cells surrounding 
the egg chamber between stages 8 and lob. 
Candidates for the regulation of yp gene expression in the ovary are expected to be 
expressed in the follicle cells during stages 8 to lOb in order to be capable of 
performing regulatory functions directly. Investigation of potential transcription 
factors responsible for the regulation of yp expression by in situ hybridisation did not 
reveal any likely candidates. The ovarian expression patterns of the aef-1, sibo and 
dsx genes were investigated by in situ hybridisation, but none of these showed 
expression patterns in the follicle cells surrounding the egg chamber and then the 
oocyte during stages 8 to lob. As yet, no transcription factors have been identified 
for the regulation of yp expression in the ovary. 
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Previous experiments to identify enhancers governing yp3 expression revealed a 
328bp fragment, located immediately upstream oftheyp3 coding sequence, sufficient 
to confer an ovarian yp expression pattern (Ronaidson and Bownes, 1995). A 15 Obp 
subfragment from this region was tested for its effects upon lacZ reporter gene 
expression in vivo by P-element mediated germ line transformation. This lSObp 
fragment was found to be capable of directing reporter gene expression in ovarian 
follicle cells during stages 8 to lOb of oogenesis, in both forward and reverse 
orientations. This suggests that the 1 5Obp fragment contains sequences responsible 
for the tissue-specific expression of yp3 in the ovary. 
6.3 THE PRODUCTION OF DOUBLESEX ANTIBODIES 
Antibodies were made to the DSX DNA binding domain protein, which was 
synthesised in K coli as a glutathione-S-transferase fusion protein. The DSX 
antibodies were produced with the aim of investigating DSX protein expression in 
male and female fat bodies, considering that the DSX proteins are proposed to be 
regulators of fat body-specific yp expression. It was also hoped that the DSX 
antibodies could verify that DSX protein is not present in the ovary. These DSX 
antibodies were used in preliminary experiments; they showed good recognition of 
GST-DSX, but the results obtained with Drosophila tissue samples were less 
conclusive, it may be necessary to affinity purify the DSX antibodies in order to 
increase their specificity in immunodetection studies. 
6.4 CONCLUDING REMARKS 
Initially, the yolk protein genes of Drosophila were considered to provide an ideal 
system to identify factors involved in the transcriptional control of sex- and tissue-
specificity during highly co-ordinated developmental stages. As research projects 
have progressed, it has become clear that the regulation of the Drosophila yp genes is 
not as simple as initially thought. Like many other eukaryotic genes, multiple binding 
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sites for various different trans-acting factors have been identified. Although models 
have been proposed for the regulation of the yps, these studies have mainly been 
focused on a single enhancer element. This element is contained within the fat body 
enhancer (FBE) of ypi and yp2, however, there are additional binding sites located 
within this enhancer, and the FBE can be deleted without preventing female, fat body 
yp expression, thus suggesting there are more sites to be located. Therefore, complete 
characterisation of gene regulation foryp] and yp2 is still far from being achieved. The 
regulation of ypi and yp2 has additional complications because the enhancer elements 
are shared between the two genes, this indicates that the regulation of yp3 may be 
simpler since the yp3 enhancer elements are not shared. However, results obtained in 
this project suggest that the regulatory mechanisms involved in regulating yp3 fat 
body expression may not be the same as forypl and yp2. 
It would be interesting to identify all the trans-acting factors involved in the 
transcriptional regulation of all three yolk protein genes, and to determine if the 
mechanism or organisation of the factors is different for the fat body regulation of 
yp3 compared with yp] and yp2. 
An important discovery in this field would be the identification of ovarian trans-
acting factors involved in the transcriptional regulation of the three yolk protein genes 
since none have been identified to date. The continuous action of the sex 
determination hierarchy is not involved in the regulation of the yp genes in the ovary, 
but the actual factors and mechanisms involved remain to be elucidated. It would also 
be interesting to find out if the ovarian regulation of yp3 is different to that of ypi and 
yp2. 
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